https://biolegacyresearch.com/busy-takeda-takes-out-tigenix-in-630m-deal/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/pernix-takes-the-ax-to-22-of-workforce-in-reorg/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/longtime-ceo-at-bay-areas-oncomed-steps-down/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/kbp-biosciences-lands-76m-an-ex-glaxosmithkline-exec-as-its-new-ceo-and-a-hq-move-to-philly/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-could-outperform-in-2018/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/biocryst-advancing-potential-treatment-for-rare-and-severely-debilitating-fibrodysplasia-ossifica/ 2018-01-05T00:00:00+00:00 https://biolegacyresearch.com/report-flags-price-transparency-as-a-key-issue-for-2018/ 2018-01-05T23:16:30+00:00 https://biolegacyresearch.com/after-kickback-scandal-ends-charitys-free-drug-program-oig-urges-phrma-to-step-in/ 2018-01-05T23:17:31+00:00 https://biolegacyresearch.com/cber-director-touts-pdufa-progress-therapeutic-firsts-in-fiscal-2017/ 2018-01-05T23:18:17+00:00 https://biolegacyresearch.com/appeals-court-overturns-infringement-finding-against-apotex/ 2018-01-05T23:19:05+00:00 https://biolegacyresearch.com/johnson-johnson-dives-into-2018-with-15-new-deals/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/pfizer-to-cut-300-jobs-as-it-ends-alzheimers-parkinsons-quest/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/new-jerseys-leading-pharma-llc-scores-40m/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-freenome/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/teva-alder-biopharma-forge-200m-anti-cgrp-based-therapy-pact/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/struggling-acorda-is-exploring-a-sale-shares-jump/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/alder-announces-250m-committed-equity-financing/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/rejected-again-ablynx-turns-down-novo-nordisks-sweetened-3-1b-bid/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-to-take-a-3b-tax-hit-in-q4-2017/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/besties-regeneron-and-sanofi-add-another-1b-to-pd-1-io-deal/ 2018-01-08T00:00:00+00:00 https://biolegacyresearch.com/fda-wont-raise-the-bar-for-drugs-referencing-novo-nordisk/ 2018-01-08T23:57:17+00:00 https://biolegacyresearch.com/fda-and-ctti-launch-patient-forum-to-boost-engagement-in-drug-development/ 2018-01-08T23:58:09+00:00 https://biolegacyresearch.com/mexican-drugmaker-warned-for-adulterated-product/ 2018-01-08T23:59:06+00:00 https://biolegacyresearch.com/axovants-nightmare-week-continues-after-ceo-admits-numbers-were-even-worse-than-reported-yesterday/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/germanys-novaliq-sets-up-u-s-subsidiary-in-cambridge-massachusetts/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-cirius-therapeutics/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/pfizer-backs-and-inks-162m-deal-with-tiny-adapsyn-bioscience/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/5-top-biotech-stocks-that-look-vulnerable-in-2018/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-bay-area-global-blood-therapeutics-sickle-cell-drug-a-breakthrough/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/regenxbio-banks-on-strong-gene-therapy-pipeline-and-potential-partnerships/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/jobs-lost-as-cellectar-biosciences-shutters-manufacturing-operations/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/bridging-clinical-research-clinical-health-care-how-to-improve-patient-centricity/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/socals-evolus-files-for-75m-ipo/ 2018-01-09T00:00:00+00:00 https://biolegacyresearch.com/amneal-handed-483-for-faulty-cleaning-quality-procedures/ 2018-01-09T00:00:03+00:00 https://biolegacyresearch.com/correction/ 2018-01-09T00:03:15+00:00 https://biolegacyresearch.com/senate-committee-probes-hhs-nominee-azars-role-in-eli-lilly-price-hikes/ 2018-01-09T23:31:06+00:00 https://biolegacyresearch.com/charity-claims-federal-policies-on-drug-assistance-violate-first-amendment/ 2018-01-09T23:32:53+00:00 https://biolegacyresearch.com/tufts-growing-volumes-of-clinical-data-are-slowing-drug-development/ 2018-01-09T23:33:45+00:00 https://biolegacyresearch.com/chinese-manufacturer-cited-for-sanitation-sterility-issues/ 2018-01-09T23:34:41+00:00 https://biolegacyresearch.com/watch-out-gilead-is-not-done-shopping/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/nestle-emerges-as-the-frontrunner-for-merck-kgaas-5b-consumer-health-biz/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/biotech-unicorn-moderna-details-game-plan-reveals-infectious-disease-programs/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/7-key-products-that-could-help-dig-valeant-out-of-its-hole/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/mabvax-ceo-looks-for-potential-deals-at-jpm-to-support-its-human-antibody-programs/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/superstar-cher-escalates-feud-with-nanthealths-soon-shiong/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/adaptimmunes-cmo-moves-forward-with-spear-t-cell-therapies/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-boragen/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-is-eyeing-pfizers-15b-consumer-biz/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/forensic-exam-shows-pattern-in-4-deaths-of-sanofi-dengue-vaccine-recipients/ 2018-01-10T00:00:00+00:00 https://biolegacyresearch.com/ec-committee-reviews-340b-drug-pricing-program-offers-recommendations/ 2018-01-10T23:33:25+00:00 https://biolegacyresearch.com/cder-celebrates-novel-approvals-and-highlights-other-firsts-in-2017/ 2018-01-10T23:34:21+00:00 https://biolegacyresearch.com/south-dakota-tribes-sue-opioid-drugmakers-for-rico-violations/ 2018-01-10T23:35:11+00:00 https://biolegacyresearch.com/ema-publishes-new-guidance-on-rheumatoid-arthritis-drug-trials/ 2018-01-10T23:36:11+00:00 https://biolegacyresearch.com/the-best-time-to-apply-for-a-job/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/fda-panel-rejects-lipocines-testosterone-pill/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/bill-gates-makes-plea-to-healthcare-capitalists-biotechs-to-help-change-the-world/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/2-under-the-radar-pharma-ma-targets-for-2018/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/suitors-weigh-bids-for-sanofis-3b-european-generics-biz/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/ptc-therapeutics-ceo-to-fight-for-dmd-therapy-pushes-forward-with-sma-treatment/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/the-7-best-life-science-companies-to-work-for-in-2018/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-hyalex-orthopaedics/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/4-major-biopharmas-what-went-down-at-jpm-2018/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/teva-board-members-take-50-pay-cut/ 2018-01-11T00:00:00+00:00 https://biolegacyresearch.com/fda-policy-roadmap-targets-opioid-addiction-strengthening-generic-competition/ 2018-01-11T22:15:52+00:00 https://biolegacyresearch.com/study-fda-should-increase-social-media-use-to-issue-safety-information/ 2018-01-11T22:16:00+00:00 https://biolegacyresearch.com/cellmark-hit-with-consent-decree-over-cancer-treatment-ads/ 2018-01-11T22:47:29+00:00 https://biolegacyresearch.com/philips-to-move-north-american-hq-and-its-2000-employees-to-cambridge/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/ipsen-names-new-ceo-for-its-north-america-biz/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/meet-the-little-known-biotech-and-its-ceo-going-after-alzheimers-hard/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-gets-expanded-fda-win-for-fluarix/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/sage-therapeutics-looks-to-file-nda-for-postpartum-depression-treatment-later-this-year/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/biotechs-froth-as-famed-startup-incubator-y-combinator-joins-100b-anti-aging-quest/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-cbt-pharmaceuticals/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/roches-star-ms-drug-snags-eu-approval/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/6-blood-testing-startups-hoping-to-be-the-next-theranos-the-good-version/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-employee-pleads-with-ceo-lawmakers-to-help-save-daca/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/fda-green-lights-astrazeneca-mercks-lynparza-for-metastatic-breast-cancer/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/athenex-moves-forward-with-205m-new-york-plant/ 2018-01-12T00:00:00+00:00 https://biolegacyresearch.com/alnylam-ceo-calls-out-trumps-alleged-immigration-remarks/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/struggling-teva-gets-another-hit-fined-for-foreign-bribes/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/meet-the-former-pfizer-husband-and-wife-team-who-founded-biotech-transpharm/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/google-backs-vaccitechs-27m-series-a-funding-round/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-corbin-therapeutics/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/5-tasty-takeover-targets-for-2018/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/rigel-pharma-awaits-fda-approval-for-tavalisse-builds-commercial-org-for-drug-launch/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/u-s-asset-manager-wants-in-on-china-biotech-unicorn-innovent-biologics-200m-ipo/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/3-biopharmas-worth-watching-in-2018/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/telix-pharmaceuticals-establishes-japanese-subsidiary-appoints-key-executives/ 2018-01-15T00:00:00+00:00 https://biolegacyresearch.com/fda-approved-78-andas-six-first-time-generics-in-december/ 2018-01-15T21:35:00+00:00 https://biolegacyresearch.com/clinic-manager-admits-to-131-million-medicare-fraud-for-controlled-substances/ 2018-01-15T21:35:00+00:00 https://biolegacyresearch.com/german-firm-cited-for-procedural-quality-control-shortcomings/ 2018-01-15T21:35:00+00:00 https://biolegacyresearch.com/bioethicists-say-right-to-try-legislation-will-have-minimal-effect-on-drug-access/ 2018-01-15T21:35:00+00:00 https://biolegacyresearch.com/fda-to-release-clinical-study-reports-and-possibly-select-crls/ 2018-01-16T23:39:42+00:00 https://biolegacyresearch.com/fda-delays-intended-use-rule-implementation-amid-industry-outcry/ 2018-01-16T23:40:55+00:00 https://biolegacyresearch.com/fda-and-dod-unveil-medical-product-program-for-military/ 2018-01-16T23:42:02+00:00 https://biolegacyresearch.com/gao-fda-should-announce-plans-to-revise-product-specific-guidances-for-nbcds-in-advance/ 2018-01-16T23:43:33+00:00 https://biolegacyresearch.com/lawsuit-vtesse-misused-confidential-data-to-develop-breakthrough-drug/ 2018-01-16T23:45:04+00:00 https://biolegacyresearch.com/the-biggest-winners-and-losers-of-jpm-2018/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/bostons-restorbio-sets-terms-for-85m-ipo/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/how-this-little-biopharma-could-beat-amgen-teva-to-the-migraine-finish-line/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/aeterna-zentaris-forges-24m-tie-up-with-strongbridge/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-shepherd-therapeutics/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/novartis-kymriah-snags-speedy-review-from-the-fda-ema/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/regeneron-keeps-science-at-the-center/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/watch-out-cambridge-biotech-makes-a-comeback/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/chinese-bidders-circle-johnson-johnsons-4b-diabetes-biz/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/help-wanted-amazon-seeks-health-privacy-expert-for-new-initiative/ 2018-01-17T00:00:00+00:00 https://biolegacyresearch.com/ema-to-juggle-brexit-and-new-quality-and-safety-guidelines-next-year/ 2018-01-17T23:05:44+00:00 https://biolegacyresearch.com/fda-highlights-conops-progress/ 2018-01-17T23:06:35+00:00 https://biolegacyresearch.com/dr-reddys-settles-unsafe-packaging-case-with-justice-department/ 2018-01-17T23:07:21+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-targets-firms-for-gmp-other-violations/ 2018-01-17T23:09:24+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-italian-indian-and-chinese-firms/ 2018-01-17T23:10:21+00:00 https://biolegacyresearch.com/common-rule-revisions-delayed-for-six-months-but-certain-changes-can-continue/ 2018-01-17T23:41:33+00:00 https://biolegacyresearch.com/medical-countermeasures-are-an-fda-priority-gottlieb-tells-lawmakers/ 2018-01-17T23:42:29+00:00 https://biolegacyresearch.com/gao-medicares-opioid-use-monitoring-lets-at-risk-patients-fall-through-the-cracks/ 2018-01-17T23:43:30+00:00 https://biolegacyresearch.com/imprimis-hit-with-warning-letter-amidst-lawsuit/ 2018-01-17T23:44:24+00:00 https://biolegacyresearch.com/allergan-could-bank-1b-by-unloading-its-anti-infectives-biz/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-gets-hit-after-court-invalidates-cancer-patent-making-room-for-rivals/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/booming-homology-inks-deal-for-huge-new-massachusetts-hq/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-carma-therapeutics/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/what-happens-to-the-fda-if-the-government-shuts-down/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/why-a-celgene-juno-marriage-makes-perfect-sense/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/3-broker-favorite-biopharmas-your-portfolio-must-have/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/celgene-to-create-biopharma-incubator-on-new-jersey-rd-site/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-ceo-continues-restructuring-with-job-cuts-in-africa/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/5-healthcare-systems-to-launch-new-generic-drug-company/ 2018-01-18T00:00:00+00:00 https://biolegacyresearch.com/cdrh-seeks-participants-for-manufacturing-and-product-quality-pilot-program/ 2018-01-18T17:45:46+00:00 https://biolegacyresearch.com/aha-urges-greater-fda-cybersecurity-oversight-of-devicemakers/ 2018-01-18T17:47:12+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-devicemakers-in-india-lithuania-texas/ 2018-01-18T17:56:02+00:00 https://biolegacyresearch.com/cdrh-proposes-new-medical-device-malfunction-reporting-program/ 2018-01-18T17:58:58+00:00 https://biolegacyresearch.com/483-roundup-thirteen-device-firms-cited-for-noncompliances/ 2018-01-18T18:00:16+00:00 https://biolegacyresearch.com/tga-logs-more-adverse-event-reports-for-devices/ 2018-01-18T18:02:31+00:00 https://biolegacyresearch.com/fda-to-expand-least-burdensome-approach-across-product-lifecycle/ 2018-01-18T18:03:25+00:00 https://biolegacyresearch.com/international-drugmakers-plan-for-higher-costs-as-brexit-looms/ 2018-01-18T18:17:31+00:00 https://biolegacyresearch.com/senate-committee-grills-azar-on-eli-lilly-price-hikes/ 2018-01-18T18:19:25+00:00 https://biolegacyresearch.com/quality-system-issues-dominate-mhras-gdp-report/ 2018-01-18T18:23:18+00:00 https://biolegacyresearch.com/emas-chmp-recommends-seven-medicines-for-approval/ 2018-01-18T18:24:41+00:00 https://biolegacyresearch.com/china-fda-to-require-registration-training-of-medical-reps/ 2018-01-18T18:25:38+00:00 https://biolegacyresearch.com/fda-releases-compounding-policy-priorities/ 2018-01-18T23:12:25+00:00 https://biolegacyresearch.com/senate-bill-would-expand-medication-assisted-therapy-options/ 2018-01-18T23:13:13+00:00 https://biolegacyresearch.com/ptab-throws-out-janssen-patent-for-prostate-cancer-drug/ 2018-01-18T23:14:02+00:00 https://biolegacyresearch.com/up-and-coming-chinese-biotech-beigene-gets-750m-worth-of-love-from-u-s-investors/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/new-yorks-tyme-jumps-as-pancreatic-cancer-drug-shines-in-early-stage-study/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/why-this-seattle-biotech-could-be-an-ma-target/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/heptares-co-founder-resigns-as-vp-and-cso-of-parent-company-sosei/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-jecure-therapeutics/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/tevas-job-cuts-hit-208-philadelphia-employees/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/shires-incoming-financial-head-honcho-finally-gets-a-start-date/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/this-cancer-drug-could-bring-in-3-8b-for-astrazeneca/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/little-known-life-science-hedge-fund-dethroning-ackmans-pershing-square/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/bay-area-biotech-perlaras-rare-strategy-for-getting-ahead-telling-the-truth/ 2018-01-19T00:00:00+00:00 https://biolegacyresearch.com/hospital-systems-form-nonprofit-generic-drugmaker-to-beat-shortages-price-hikes/ 2018-01-19T23:35:54+00:00 https://biolegacyresearch.com/cder-plans-to-issue-almost-100-new-or-revised-draft-guidances-in-2018/ 2018-01-19T23:36:47+00:00 https://biolegacyresearch.com/janssen-sues-teva-for-infringing-invega-sustanna-patents/ 2018-01-19T23:37:39+00:00 https://biolegacyresearch.com/merck-and-glenmark-face-class-action-over-zetia-monopoly-claims/ 2018-01-19T23:38:28+00:00 https://biolegacyresearch.com/fda-nails-yicheng-chemical-for-contamination-documentation-concerns/ 2018-01-19T23:39:24+00:00 https://biolegacyresearch.com/government-shutdown-temporarily-ends-or-slows-some-fda-work/ 2018-01-21T21:46:00+00:00 https://biolegacyresearch.com/deal-spree-continues-as-celgene-nabs-juno-in-9b-deal/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/hepatares-co-founder-to-helm-mercks-new-rd-center-in-the-uk/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/sanofi-ceo-finally-scores-with-11-6b-buyout-of-biogens-spinoff-bioverativ/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-eureka-therapeutics-banks-60m/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-indalo-therapeutics/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/astellas-vicals-lead-cmv-vaccine-flunks-key-phase-iii-study/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/most-wanted-life-sciences-employers-in-genetown/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/idera-biocryst-tie-the-knot-and-transform-into-a-rare-disease-pharma/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-adamas-pharma-pays-big-bucks-to-double-hq/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/3-diabetes-biotechs-that-could-surge-50-or-more-in-2018/ 2018-01-22T00:00:00+00:00 https://biolegacyresearch.com/appeals-court-upholds-dismissal-of-pfizer-testosterone-lawsuits-citing-fdc-preemption/ 2018-01-22T22:21:03+00:00 https://biolegacyresearch.com/fda-clarifies-conditions-for-mixing-diluting-or-repackaging-biologics/ 2018-01-22T22:23:47+00:00 https://biolegacyresearch.com/milan-laboratories-cited-over-quality-control-sanitary-concerns/ 2018-01-22T22:24:41+00:00 https://biolegacyresearch.com/lawmakers-end-federal-shutdown-for-three-weeks-at-least/ 2018-01-22T23:01:51+00:00 https://biolegacyresearch.com/paragon-bioservices-to-create-200-new-jobs-in-expansion/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-formed-by-4-ex-pfizer-employees-inks-deal-with-former-employer/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/top-3-takeover-targets-for-pfizer/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-fortis-therapeutics/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/denali-top-exec-jumps-ship-for-bay-area-anti-aging-startup-alkahest/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/new-kid-tmunity-banks-100m-from-gilead-and-facebook-billionaire-sean-parker/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-gigagen-moves-to-new-space-to-accommodate-growth/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-have-doubled-investors-money-in-less-than-a-year/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/gileads-kite-pays-135m-for-ex-agensys-rd-building/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/amgen-jumps-as-migraine-drug-wows-in-late-stage-study/ 2018-01-23T00:00:00+00:00 https://biolegacyresearch.com/cbers-2018-guidance-agenda-features-gene-therapies-blood-products/ 2018-01-23T23:10:59+00:00 https://biolegacyresearch.com/dea-regulation-conforms-with-cara-to-combat-opioid-crisis/ 2018-01-23T23:11:46+00:00 https://biolegacyresearch.com/lawsuit-claims-fda-hurt-research-firms-reputation/ 2018-01-23T23:12:33+00:00 https://biolegacyresearch.com/hong-kong-drugmaker-warned-for-quality-control-procedural-shortcomings/ 2018-01-23T23:13:25+00:00 https://biolegacyresearch.com/flushed-with-cash-shanghai-pharma-hunts-for-ma-in-the-u-s-and-europe/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/why-this-connecticut-biotech-could-be-a-1m-opportunity-for-investors/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/jj-to-spend-more-on-rd-with-tax-reform-money/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/top-trends-impacting-biopharma-innovation-strategy-in-2018/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/how-high-novo-nordisk-could-and-should-go-for-ablynx/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-surrozen/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/5-biotechs-drawing-buyout-buzz-in-2018/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/novartis-poised-for-growth-as-ceo-hands-baton-to-successor/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/why-this-heart-drug-could-be-a-5b-blockbuster-for-novartis/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/ai-biotech-startup-xtalpi-scores-15m-from-google-tencent-and-sequoia/ 2018-01-24T00:00:00+00:00 https://biolegacyresearch.com/alex-azar-confirmed-by-senate-as-next-secretary-of-hhs/ 2018-01-24T23:12:58+00:00 https://biolegacyresearch.com/circuit-court-sides-with-ptab-on-invalidating-jjs-remicade-patent/ 2018-01-24T23:14:01+00:00 https://biolegacyresearch.com/fda-and-ftc-go-after-firms-selling-unproven-opioid-treatments/ 2018-01-24T23:14:53+00:00 https://biolegacyresearch.com/gsk-and-jj-lead-in-addressing-antimicrobial-resistance-report-says/ 2018-01-24T23:15:42+00:00 https://biolegacyresearch.com/ema-recommended-more-drugs-for-marketing-authorizations-in-2017/ 2018-01-24T23:16:37+00:00 https://biolegacyresearch.com/rumor-alert-allergan-in-talks-to-buy-out-kandy-therapeutics-in-400m-deal/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/outgoing-novartis-ceo-hunts-for-his-next-big-challenge/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/takeda-becomes-the-latest-to-notch-an-alzheimers-failure-under-its-belt/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/big-names-in-biotech-seek-1m-to-build-life-size-statue-of-legend-henri-termeer/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-immune-onc-therapeutics/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/at-last-eli-lilly-publishes-data-for-catastrophic-alzheimers-trial/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/cellectis-ceo-provides-update-on-ucart-programs-and-laser-focus-of-company-in-2018/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/novartis-buys-access-to-sparks-landmark-gene-therapy-drug-with-170m-deal/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/former-merrimack-sanofi-execs-launch-boston-cancer-startup/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/uks-dechra-spends-422-1m-on-two-dutch-animal-pharmas/ 2018-01-25T00:00:00+00:00 https://biolegacyresearch.com/fda-drops-biennial-inspection-requirement-for-biologics/ 2018-01-25T22:57:56+00:00 https://biolegacyresearch.com/fda-guidance-on-combination-hypertension-drugs-offers-alternatives-to-larger-trials/ 2018-01-25T22:58:36+00:00 https://biolegacyresearch.com/fda-endo-pause-bulk-compounding-lawsuit-pending-fda-guidance/ 2018-01-25T22:59:20+00:00 https://biolegacyresearch.com/fda-warns-australian-firm-for-gmp-violations/ 2018-01-25T23:00:02+00:00 https://biolegacyresearch.com/valeant-to-shave-an-additional-200m-from-its-mountain-of-debt/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/jj-bows-out-of-race-for-pfizers-20b-consumer-health-biz/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/why-bay-areas-xoma-surged-700-in-2017-by-not-making-drugs/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-fibrocor-therapeutics/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/novartis-bet-pays-off-as-advanced-accelerator-applications-wins-fda-nod-for-lutathera/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/novelion-to-cut-an-unknown-number-of-jobs-in-restructuring/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/astrazenecas-three-in-one-copd-inhaler-succeeds-in-phase-iii-trial/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/incoming-novartis-ceo-bayer-leader-join-president-trump-for-private-dinner-at-davos/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/ballsy-celgene-continues-to-tread-carefully-into-neurosciences/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/spectris-snaps-up-concept-life-sciences-in-163m-deal/ 2018-01-26T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-outlines-fdas-approach-to-precision-medicines-in-davos/ 2018-01-26T22:52:04+00:00 https://biolegacyresearch.com/court-rules-fda-didnt-apply-double-standard-to-jj-amgen-exclusivity-applications/ 2018-01-26T22:52:45+00:00 https://biolegacyresearch.com/judge-rules-fdas-denial-of-exclusivity-to-amneal-was-legal/ 2018-01-26T22:53:33+00:00 https://biolegacyresearch.com/stakeholders-prefer-tgas-modified-approach-to-naming-biologics-over-fdas-suffixes/ 2018-01-26T22:54:33+00:00 https://biolegacyresearch.com/mexican-drugmaker-cited-for-multiple-violations/ 2018-01-26T22:55:15+00:00 https://biolegacyresearch.com/3-small-biotechs-big-drugmakers-are-making-googly-eyes-at/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-roches-autism-drug-a-breakthrough/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/abbvie-to-award-shareholders-increase-employees-pay-on-rosy-2018-forecast/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/fda-formally-rejects-aradigms-linhaliq-requests-a-new-phase-iii-trial-for-reconsideration/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-apostle/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/apotex-ceo-abruptly-resigns-amid-allegations-of-trade-secret-leaks/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/6-promising-biopharmas-with-major-catalysts-in-2018/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/5-drugmakers-that-are-soaring-insanely-high-right-now/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/filing-reveals-kendall-squares-invivo-therapeutics-is-burning-through-cash-fast/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/fda-shuts-down-addiction-study-after-monkey-deaths/ 2018-01-29T00:00:00+00:00 https://biolegacyresearch.com/socals-artelo-biosciences-inks-202m-rd-deal-with-the-neomed-institute/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/why-boston-bound-alexion-could-be-a-compelling-ma-for-larger-drugmakers/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/unknown-group-of-traders-earned-4-9m-before-sanofi-bioverativ-deal/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-dmd-therapeutics/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/one-year-old-dracen-pharma-raises-40-5m-hunts-for-office-and-lab-space-with-plans-to-hire/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/bridgebio-launches-qed-therapeutics-with-65m-and-an-abandoned-novartis-cancer-program/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/3-overlooked-biopharmas-insiders-are-snapping-up/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/shire-snaps-up-rights-to-a-preclinical-autoimmune-candidate-for-undisclosed-sum/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/little-exonics-adds-mercks-larger-than-life-rd-chief-to-its-board-of-directors/ 2018-01-30T00:00:00+00:00 https://biolegacyresearch.com/fda-says-sponsors-seeking-qidp-and-fast-track-designations-must-apply-for-both/ 2018-01-30T00:22:02+00:00 https://biolegacyresearch.com/fda-clarifies-stance-on-clinical-trial-reimbursements-for-patient-travel-lodging/ 2018-01-30T00:23:38+00:00 https://biolegacyresearch.com/abbvie-scores-first-full-bellwether-win-in-androgel-lawsuits/ 2018-01-30T00:24:37+00:00 https://biolegacyresearch.com/agreement-cuts-common-canadian-generics-prices-by-up-to-40-percent/ 2018-01-30T00:25:39+00:00 https://biolegacyresearch.com/u-k-drugmaker-hit-for-having-no-quality-unit/ 2018-01-30T00:26:53+00:00 https://biolegacyresearch.com/gottlieb-outlines-fda-plans-for-compounding-enforcement-to-lawmakers/ 2018-01-30T22:48:21+00:00 https://biolegacyresearch.com/aradigm-receives-crl-for-linhaliq-citing-quality-and-data-concerns/ 2018-01-30T22:49:11+00:00 https://biolegacyresearch.com/japanese-firm-slammed-for-falsifying-certificates-of-analysis/ 2018-01-30T22:49:57+00:00 https://biolegacyresearch.com/mexican-manufacturer-cited-for-quality-conformance-issues/ 2018-01-30T22:50:42+00:00 https://biolegacyresearch.com/despite-spike-why-investors-should-still-avoid-mannkind-like-the-plague/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/socals-vical-terminates-54-of-workforce-to-focus-resources-on-two-clinical-programs/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/3-cases-of-brain-damage-force-the-fda-to-slap-a-hold-on-bellicums-lead-drug/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/trump-endorses-right-to-try-experimental-drug-bill-at-state-of-the-union-address/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/new-report-jj-tops-employment-branding/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/why-abbvie-could-join-the-ma-mania-soon/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/3-big-drugmakers-with-huge-catalysts-on-the-horizon/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/on-a-roll-sage-shows-off-early-stage-insomnia-data/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/meet-the-unnoticed-alzheimers-biotech-facing-a-make-or-break-2018/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/get-ready-for-the-ma-explosion/ 2018-01-31T00:00:00+00:00 https://biolegacyresearch.com/texas-drugmaker-warned-for-misbranded-products/ 2018-01-31T22:11:00+00:00 https://biolegacyresearch.com/fda-proposes-packaging-reductions-to-curb-opioid-addiction/ 2018-01-31T22:16:35+00:00 https://biolegacyresearch.com/democrats-ask-gao-to-review-white-house-action-on-opioids-since-emergency-declaration/ 2018-01-31T22:20:00+00:00 https://biolegacyresearch.com/aam-exclusionary-biologics-contracts-will-hurt-emerging-biosimilars-market/ 2018-01-31T22:22:20+00:00 https://biolegacyresearch.com/new-big-data-study-from-mit-puts-clinical-trial-success-rate-at-14-percent/ 2018-01-31T22:23:56+00:00 https://biolegacyresearch.com/teva-wraps-up-703m-sale-of-global-womens-health-biz-to-cvc-capital/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/3-fda-decisions-to-look-out-for-in-february/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/newcomer-partner-therapeutics-nabs-60m-acquires-leukine-from-sanofi/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/trumps-cdc-director-resigns-over-pharma-tobacco-investments/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/booming-celltrion-falls-after-fda-warning-letter/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/lilly-exploring-strategic-alternatives-for-animal-health-biz/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/investors-elated-as-vertex-picks-two-top-cf-triple-combos-for-phase-iii-trials/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/cambridges-avrobio-lands-60m-to-push-fabry-rest-of-pipeline-into-the-clinic/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/stada-names-novartis-exec-as-new-ceo-its-fifth-leader-since-2016/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/voyager-founder-and-ceo-to-step-down-hunt-for-new-leader-begins/ 2018-02-01T00:00:00+00:00 https://biolegacyresearch.com/grocery-chains-sue-generic-drugmakers-alleging-price-fixing-conspiracy/ 2018-02-01T22:45:50+00:00 https://biolegacyresearch.com/gottlieb-pledges-to-address-flu-season-supply-shortages/ 2018-02-01T22:46:38+00:00 https://biolegacyresearch.com/teikoku-state-ags-reach-agreement-to-end-pay-for-delay-for-lidoderm-patches/ 2018-02-01T22:47:31+00:00 https://biolegacyresearch.com/ema-drafts-strengthened-guidance-on-safety-follow-up-for-advanced-therapies/ 2018-02-01T22:48:23+00:00 https://biolegacyresearch.com/mysterious-biotech-unicorn-moderna-nabs-another-500m-is-now-worth-7b/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/ma-chatter-swirls-over-amgens-70b-cashpile/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/array-biopharma-slaps-192m-lawsuit-on-astrazeneca-over-cancer-drug-royalties/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/amgen-to-build-new-300m-facility-after-tax-changes/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/arcturus-ceo-ousted-effective-immediately/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/abbvie-plans-to-hire-after-doubling-cambridge-rd-facility/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/3-best-biotherapeutics-stocks-to-buy-right-now/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/alder-biopharmaceuticals-announces-closing-of-250m-of-2-50-convertible-senior-notes-due-2025/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/tg-therapeutics-announces-updated-results-from-the-ongoing-phase-ii-study-of-ublituximab-in-patie/ 2018-02-02T00:00:00+00:00 https://biolegacyresearch.com/study-generic-substitution-could-have-saved-medicare-2-9-billion/ 2018-02-02T21:47:36+00:00 https://biolegacyresearch.com/fda-adds-black-box-warning-to-intercepts-liver-disease-medicine/ 2018-02-02T21:48:26+00:00 https://biolegacyresearch.com/new-york-ag-sues-insys-alleging-illegal-off-label-promotion-bribery-to-boost-fentanyl-drug/ 2018-02-02T21:49:15+00:00 https://biolegacyresearch.com/anti-dengue-vaccine-may-be-linked-to-three-deaths-in-the-philippines-task-force-reports/ 2018-02-02T21:50:00+00:00 https://biolegacyresearch.com/house-republicans-ask-gottlieb-for-details-on-heparin-imports-contingency-plans-for-shortage/ 2018-02-02T23:05:00+00:00 https://biolegacyresearch.com/the-stunning-golden-parachutes-of-junos-9b-celgene-deal/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/bostons-intarcia-pink-slips-60-employees-terminates-two-late-stage-trials/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/gsk-reckitt-are-the-only-suitors-for-pfizers-20b-consumer-health-biz/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/the-3-small-crispr-biotechs-that-could-cure-10000-diseases/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/3-high-risk-biotechs-that-could-pop-or-drop-in-2018/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/suitors-take-note-as-bay-areas-nektar-may-be-up-for-sale/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/eyegate-implodes-as-eye-drug-flunks-phase-ii-test/ 2018-02-05T00:00:00+00:00 https://biolegacyresearch.com/fda-unveils-data-standards-strategy-for-fy-2018-2022/ 2018-02-05T22:35:54+00:00 https://biolegacyresearch.com/insurers-sue-pfizer-over-coverage-for-400-million-off-label-marketing-settlement/ 2018-02-05T22:36:24+00:00 https://biolegacyresearch.com/cder-denies-fourth-united-therapeutics-petition-on-andas-referencing-tyvaso/ 2018-02-05T22:36:28+00:00 https://biolegacyresearch.com/nexgen-pharma-cited-for-gmp-violations/ 2018-02-05T22:36:34+00:00 https://biolegacyresearch.com/mannkind-names-lilly-exec-as-new-cmo/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/booming-visterra-outgrows-kendall-square-space-heads-to-suburbs/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-plunged-more-than-20-yesterday/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/genentechs-tecentriq-impresses-again-in-late-stage-kidney-cancer-trial/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/allergan-shows-off-phase-iii-migraine-data/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/why-this-biotech-ceo-injected-himself-with-a-diy-herpes-vaccine-on-facebook-live/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-bay-area-zogenixs-dravet-syndrome-drug-a-breakthrough/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/two-drugmakers-compete-for-sanofis-2-4b-generics-biz/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/celgenes-multiple-myeloma-triplet-succeeds-in-key-phase-iii-trial/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/meet-the-uk-biotech-developing-a-vaccine-for-every-type-of-flu/ 2018-02-06T00:00:00+00:00 https://biolegacyresearch.com/celltrion-warned-for-aseptic-practices-training-and-complaint-handling/ 2018-02-06T23:15:00+00:00 https://biolegacyresearch.com/ema-prevails-against-drugmakers-seeking-to-block-release-of-clinical-trial-data/ 2018-02-06T23:15:04+00:00 https://biolegacyresearch.com/tga-issues-risk-survey-to-drugmakers-ahead-of-first-pharmacovigilance-inspections/ 2018-02-06T23:16:46+00:00 https://biolegacyresearch.com/penalties-for-drug-falsification-vary-widely-between-eu-members/ 2018-02-06T23:17:30+00:00 https://biolegacyresearch.com/federal-circuit-affirms-dismissal-of-abbvie-lawsuit-in-medimmune-patent-dispute/ 2018-02-06T23:18:22+00:00 https://biolegacyresearch.com/gottlieb-flags-new-approaches-to-opioids-drug-pricing-internal-challenges/ 2018-02-06T23:21:00+00:00 https://biolegacyresearch.com/ousted-arcturus-founder-and-ceo-claims-he-was-improperly-pushed-out-by-4-board-members/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/2-bay-area-biotechs-that-jumped-while-its-peers-cratered/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/on-a-roll-fda-calls-sages-depression-drug-a-breakthrough/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/cambridges-enumeral-filed-for-bankruptcy-sells-assets-to-bay-areas-xoma/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/biogen-halts-plans-to-develop-tysabri-for-stroke-after-phase-iib-trial-flop/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithklines-booming-pipeline-under-ceo-emma-walmsley/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/another-day-another-breakthrough-tag-for-glaxosmithklines-bexsero/ 2018-02-07T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-considerations-for-submitting-impurity-data-as-anda-approvals-drop-in-january/ 2018-02-07T22:43:00+00:00 https://biolegacyresearch.com/health-groups-say-right-to-try-could-do-more-harm-than-good/ 2018-02-07T22:44:00+00:00 https://biolegacyresearch.com/macfarlan-smith-cited-for-gmp-deficiencies/ 2018-02-07T22:45:00+00:00 https://biolegacyresearch.com/fda-publishes-guidance-on-microbiology-data-for-antibacterial-drugs/ 2018-02-07T22:53:33+00:00 https://biolegacyresearch.com/madrigals-cholesterol-drug-succeeds-in-mid-stage-trial/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/interview-insider-tips-on-how-to-get-hired-at-five-prime-therapeutics/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-rani-therapeutics-lands-53m-as-company-moves-to-clinical-trials/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/cancer-biotech-novocure-scores-new-150m-debt-financing/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/teva-continues-restructuring-with-46-cuts-in-pennsylvania/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/sanofi-abandons-multiple-mid-stage-drug-programs/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/arbutus-cuts-31-of-global-workforce-to-shutter-its-burnaby-facility/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/amicus-releases-more-impressive-pompe-disease-data-at-worldsymposium/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/gilead-elated-as-the-fda-oks-new-blockbuster-hiv-pill-biktarvy/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/interview-insider-tips-on-how-to-get-hired-at-vertex-pharmaceuticals/ 2018-02-08T00:00:00+00:00 https://biolegacyresearch.com/fda-publishes-57-product-specific-guidances-for-generics/ 2018-02-08T22:37:22+00:00 https://biolegacyresearch.com/viiv-healthcare-sues-gilead-for-patent-infringement-following-approval-of-hiv-drug/ 2018-02-08T22:38:03+00:00 https://biolegacyresearch.com/law-firm-seeks-to-reopen-fraud-case-against-allergan-subsidiary/ 2018-02-08T22:38:58+00:00 https://biolegacyresearch.com/bioverativ-execs-snagged-a-nice-payday-after-sanofi-deal/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/novartis-sandoz-jobs-on-the-chopping-block/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/neuro-startup-makes-debut-with-20-9m-from-novo-johnson-johnson/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/genomics-startup-emerges-from-stealth-mode-by-leading-harvard-geneticist/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/immunoprecise-brings-on-new-ceo/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/boston-based-biotech-inks-immuno-oncology-pact-with-seattle-genetics/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/teva-ceo-says-2018-will-be-a-year-of-falling-sales-and-profits/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/allergan-snaps-up-sydney-biotech-for-upfront-payment-of-us-95m/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/clinical-stage-biotech-stock-might-outperform-amgen/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/tevas-cgrp-migraine-med-hits-a-stumbling-block/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/boehringer-ingelheim-ditches-phase-ii-alzheimers-program/ 2018-02-09T00:00:00+00:00 https://biolegacyresearch.com/bipartisan-senate-bill-would-give-nih-more-leeway-to-explore-opioid-alternatives/ 2018-02-09T22:30:14+00:00 https://biolegacyresearch.com/wuhan-warned-for-quality-controls-adulterated-products/ 2018-02-09T22:31:00+00:00 https://biolegacyresearch.com/budget-deal-boosts-discretionary-spending-but-unclear-how-much-fda-will-benefit/ 2018-02-09T22:35:38+00:00 https://biolegacyresearch.com/cea-report-how-government-can-reduce-drug-prices-increase-innovation-in-pharma/ 2018-02-09T22:37:18+00:00 https://biolegacyresearch.com/fda-officials-discuss-sentinels-challenges/ 2018-02-09T22:40:53+00:00 https://biolegacyresearch.com/amicus-investors-cheer-as-the-fda-shaves-four-months-off-its-fabry-drug-review-date/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/ramaswamys-roivant-inks-650m-rd-deal-with-this-tiny-diabetes-biotech/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-rubius-to-double-footprint-with-new-kendall-square-lease/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/cambridges-surface-oncology-promotes-cbo-to-top-job/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/genentech-shows-off-new-mid-stage-dme-data/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/axovant-ceo-david-hung-abruptly-exits-coo-and-several-directors-also-resign/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/3-drugs-that-could-make-or-break-abbvie/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/sarepta-plunged-after-adverse-event-forces-trial-halt-in-the-uk/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/3-biotech-gems-to-stock-up-on-this-month/ 2018-02-12T00:00:00+00:00 https://biolegacyresearch.com/purdue-ends-opioid-marketing-to-doctors/ 2018-02-12T22:46:21+00:00 https://biolegacyresearch.com/fda-pmrs-oxycodone-nda-did-not-include-enough-data-on-abuse-deterrent-properties/ 2018-02-12T22:47:14+00:00 https://biolegacyresearch.com/armed-with-new-patent-indivior-sues-suboxone-generics-applicants/ 2018-02-12T22:48:02+00:00 https://biolegacyresearch.com/new-fda-guidance-outlines-trial-design-for-bcg-unresponsive-nmibc-drugs/ 2018-02-12T22:49:00+00:00 https://biolegacyresearch.com/administration-requests-huge-hike-in-fda-budget-for-fy2019-increased-user-fees/ 2018-02-12T23:03:00+00:00 https://biolegacyresearch.com/eli-lillys-taltz-succeeds-in-key-phase-iii-ankylosing-spondylitis-trial/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/better-late-than-never-novartis-momenta-win-fda-approval-for-delayed-ms-drug/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/booming-lakepharma-to-create-100-new-jobs-in-massachusetts-expansion/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/vertex-scores-fda-nod-for-cf-combo-drug-sets-292000-price-tag/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/charles-river-slams-down-800m-cash-for-global-cro/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/its-confirmed-celgenes-former-ceo-and-chairman-is-making-a-run-for-the-senate/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/ai-biotech-bioxcel-therapeutics-files-for-69m-ipo/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/purdue-pharma-cuts-more-than-half-of-u-s-sales-staff-amid-opioid-crisis/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/walgreens-makes-a-takeover-play-for-drug-distributor-amerisourcebergen/ 2018-02-13T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-summarizes-new-initiatives-under-administrations-proposed-budget-increase/ 2018-02-13T22:45:07+00:00 https://biolegacyresearch.com/industry-groups-welcome-administrations-fda-budget-request-with-some-reservations/ 2018-02-13T22:46:02+00:00 https://biolegacyresearch.com/sens-mccain-baldwin-ask-trump-to-support-bill-on-drug-price-increases/ 2018-02-13T22:48:26+00:00 https://biolegacyresearch.com/drugmaker-payments-to-advocacy-groups-may-have-fueled-opioid-epidemic-senator-asserts/ 2018-02-13T22:49:22+00:00 https://biolegacyresearch.com/allergan-agrees-to-settle-botox-antitrust-case-for-13-45-million/ 2018-02-13T22:50:19+00:00 https://biolegacyresearch.com/bayer-facility-warned-for-gmp-noncompliance/ 2018-02-13T22:51:15+00:00 https://biolegacyresearch.com/fda-declares-pfizers-atopic-dermatitis-drug-a-breakthrough/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/merck-chemist-arrested-for-stealing-deadly-chemical/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/tetraphases-lead-antibiotic-fails-another-late-stage-study/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-facing-stiff-headwinds-in-2018/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/an-unrelenting-disaster-zone-mercks-alzheimers-drug-fails-in-phase-iii/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/meet-the-little-known-chinese-car-t-biotech-up-more-than-500-since-june-2017/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/fda-berates-bayer-for-inadequate-cleaning-qc-questions-at-hq/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/jobs-affected-as-immunogen-winds-down-ops-at-massachusetts-facility/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/japans-astellas-pays-102-5m-for-u-s-biotech-universal-cells/ 2018-02-14T00:00:00+00:00 https://biolegacyresearch.com/azar-defends-fy-2019-budget-request-at-congressional-hearing/ 2018-02-14T22:50:20+00:00 https://biolegacyresearch.com/fda-finalizes-guidance-on-co-crystals-in-ndas-and-andas/ 2018-02-14T22:51:09+00:00 https://biolegacyresearch.com/cellectis-t-cell-gene-editing-technology-granted-patents/ 2018-02-14T22:51:56+00:00 https://biolegacyresearch.com/medtech-petitions-fda-for-permission-to-change-dosage-in-anda-for-generic-excedrin/ 2018-02-14T22:52:54+00:00 https://biolegacyresearch.com/guangzhou-facility-warned-for-deficient-procedures/ 2018-02-14T22:53:54+00:00 https://biolegacyresearch.com/2-biotechs-with-the-potential-of-doubling-investors-cash/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/oxford-biomedica-wins-105m-gene-therapy-contract-from-bioverativ/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/beleaguered-axovant-begins-cutting-jobs-while-exiting-ceo-gets-2-6m-severance-package/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/4-small-biotech-ma-targets-for-gilead/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/teva-surges-after-warren-buffetts-berkshire-reports-358m-stake/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/jj-wins-fda-nod-for-erleada-the-first-drug-for-nonmetastatic-prostate-cancer/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/vertex-nixes-three-planned-phase-iii-cf-trials-in-france/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/gt-biopharma-promotes-coo-to-top-post-effective-immediately/ 2018-02-15T00:00:00+00:00 https://biolegacyresearch.com/fda-sets-udi-compliance-deadline-for-class-i-unclassified-devices/ 2018-02-15T17:21:18+00:00 https://biolegacyresearch.com/imdrf-updates-device-safety-and-performance-assessment-guidelines/ 2018-02-15T17:22:38+00:00 https://biolegacyresearch.com/fda-drafts-guidance-on-replacing-reagents-for-ivd-devices/ 2018-02-15T17:23:28+00:00 https://biolegacyresearch.com/medical-laser-manufacturer-draws-lengthy-fda-warning/ 2018-02-15T17:26:28+00:00 https://biolegacyresearch.com/fda-warns-bd-facility-in-ongoing-lead-test-probe/ 2018-02-15T17:27:17+00:00 https://biolegacyresearch.com/fda-warns-oregon-device-firm-over-failing-to-respond-to-inspection-issues/ 2018-02-15T17:28:17+00:00 https://biolegacyresearch.com/regulatory-hurdles-for-design-changes-stall-bsis-market-comeback/ 2018-02-15T17:29:14+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-8-device-firms-for-numerous-deficiencies/ 2018-02-15T17:30:38+00:00 https://biolegacyresearch.com/fda-to-define-gmps-for-outsourcing-facilities/ 2018-02-15T17:38:49+00:00 https://biolegacyresearch.com/warning-letter-roundup-five-firms-warned-for-misbranding-gmps/ 2018-02-15T17:42:23+00:00 https://biolegacyresearch.com/483-roundup-six-firms-flagged-for-variety-of-violations/ 2018-02-15T17:43:22+00:00 https://biolegacyresearch.com/gottlieb-outlines-fda-plans-for-compounding-enforcement/ 2018-02-15T17:46:07+00:00 https://biolegacyresearch.com/expert-committee-votes-down-nerve-block-indication-for-exparel/ 2018-02-15T22:40:37+00:00 https://biolegacyresearch.com/fda-clarifies-process-to-obtain-informal-feedback-prior-to-marketing-submissions/ 2018-02-15T22:41:24+00:00 https://biolegacyresearch.com/fda-tackles-neurological-disorders-in-five-guidances-flags-patient-input/ 2018-02-15T22:44:48+00:00 https://biolegacyresearch.com/fda-rejects-apricus-biosciences-erectile-dysfunction-cream-vitaros/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/officials-eye-new-biotech-tenants-for-bristol-myers-former-connecticut-complex/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/merck-kgaa-pfizers-lung-cancer-drug-flunks-late-stage-trial/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/drug-giant-roche-buys-former-google-execs-flatiron-in-1-9b-deal/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/why-novavax-could-be-a-millionaire-maker-stock/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/russia-allegedly-behind-mercks-cyberattack-last-year/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/fda-advisory-panel-spurns-paciras-request-for-expanded-use-of-pain-drug-exparel/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/amag-investors-cheer-as-biotech-wins-second-drug-approval-this-month/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/illumina-leaves-mission-bay-for-new-campus-in-the-peninsula/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/superstar-investors-jump-in-on-celgene-spinout-celularitys-250m-funding-round/ 2018-02-16T00:00:00+00:00 https://biolegacyresearch.com/abbvie-presents-new-phase-2b-data-on-upadacitinib-in-atopic-dermatitis/ 2018-02-19T00:00:00+00:00 https://biolegacyresearch.com/otezla-apremilast-phase-iii-data-showed-significant-improvements-in-patients-with-active-behce/ 2018-02-19T00:00:00+00:00 https://biolegacyresearch.com/abbvie-presents-new-positive-late-breaking-data-from-two-phase-3-psoriasis-trials-of-risankizumab/ 2018-02-19T00:00:00+00:00 https://biolegacyresearch.com/bayer-claims-perrigo-infringed-on-six-patents-in-anda/ 2018-02-19T21:57:00+00:00 https://biolegacyresearch.com/phrma-and-bio-say-european-commission-proposals-hurt-patent-rights/ 2018-02-19T21:57:00+00:00 https://biolegacyresearch.com/da-files-first-suit-against-opioid-makers-under-state-consumer-protection-law/ 2018-02-19T21:58:00+00:00 https://biolegacyresearch.com/fda-flags-legacy-pharmaceuticals-for-gmp-violations/ 2018-02-19T21:58:00+00:00 https://biolegacyresearch.com/fda-denies-petition-to-withdraw-approval-for-makena/ 2018-02-19T21:58:00+00:00 https://biolegacyresearch.com/fda-gives-astrazenecas-imfinzi-the-nod-for-new-lung-cancer-indication/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/dynavax-secures-175-million-in-funding-to-support-launch-of-recently-approved-heplisav-b/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/federal-court-overturns-gilead-sciences-and-merck-patent-dispute/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/abbvie-and-voyager-therapeutics-launch-1-2-billion-alzheimers-partnership/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/jj-could-explore-potential-2b-sale-of-sterilization-products-division/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/pdl-biopharma-gives-up-on-acquiring-neos-therapeutics/ 2018-02-20T00:00:00+00:00 https://biolegacyresearch.com/stakeholders-seek-clarification-of-rmat-eligibility-criteria/ 2018-02-20T22:45:23+00:00 https://biolegacyresearch.com/judge-throws-out-2-5-billion-jury-award-to-gilead-in-merck-patent-fight/ 2018-02-20T22:46:21+00:00 https://biolegacyresearch.com/fda-consolidates-focuses-mapp-document-on-ind-clinical-holds/ 2018-02-20T22:47:00+00:00 https://biolegacyresearch.com/allergan-and-co-defendants-to-pay-9-million-for-product-hopping-to-stifle-generics/ 2018-02-20T22:48:11+00:00 https://biolegacyresearch.com/stakeholders-share-thoughts-on-draft-guidance-on-targeted-therapies/ 2018-02-20T22:57:45+00:00 https://biolegacyresearch.com/abbvies-elagolix-hits-primary-endpoints-for-uterine-fibroids/ 2018-02-21T00:00:00+00:00 https://biolegacyresearch.com/could-jjs-deal-with-theravance-develop-a-replacement-for-remicade-in-ibd/ 2018-02-21T00:00:00+00:00 https://biolegacyresearch.com/11-most-innovative-life-science-companies-in-the-world/ 2018-02-21T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-evofem-biosciences-amphora-fast-track-designation/ 2018-02-21T00:00:00+00:00 https://biolegacyresearch.com/oric-pharmaceuticals-snags-50-million-to-advance-lead-asset-for-treatment-resistant-cancers/ 2018-02-21T00:00:00+00:00 https://biolegacyresearch.com/novo-nordisks-positive-phase-iii-data-for-oral-diabetic-drug-heats-up-the-competition/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/novartis-eyes-2019-for-launch-of-investigational-namd-treatment/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/achillion-slashes-staff-and-initiates-restructuring-following-termination-of-jj-deal/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/cannabis-company-gw-pharmaceuticals-seizure-drug-flunks-phase-ii-trial/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/reported-side-effects-raise-concerns-for-regenerons-eylea/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/kallyope-snags-66m-in-series-b-to-continue-gut-brain-axis-research/ 2018-02-22T00:00:00+00:00 https://biolegacyresearch.com/developers-voice-concern-over-draft-guidance-closing-orphan-drug-loophole/ 2018-02-22T00:00:24+00:00 https://biolegacyresearch.com/fda-releases-draft-guidance-on-bimo-inspection-submission-requirements/ 2018-02-22T00:01:29+00:00 https://biolegacyresearch.com/judge-rules-fda-properly-denied-amgen-six-month-exclusivity-for-sensipar/ 2018-02-22T00:02:00+00:00 https://biolegacyresearch.com/fda-sends-untitled-letter-to-collegium-over-extended-release-oxycodone/ 2018-02-22T00:04:01+00:00 https://biolegacyresearch.com/bray-group-cited-for-multiple-gmp-violations/ 2018-02-22T00:05:15+00:00 https://biolegacyresearch.com/fda-regs-plunged-in-2017-but-other-developments-built-on-obama-era-trends/ 2018-02-22T22:58:17+00:00 https://biolegacyresearch.com/opioid-painkillers-can-increase-risk-of-meningitis-pneumonia-infection-study-finds/ 2018-02-22T22:59:00+00:00 https://biolegacyresearch.com/lawmakers-call-for-azars-intervention-on-hcv-drug-prices/ 2018-02-22T22:59:57+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-combination-hypertension-drug-development/ 2018-02-22T23:37:34+00:00 https://biolegacyresearch.com/gottlieb-outlines-fdas-approach-to-precision-medicines/ 2018-02-22T23:39:20+00:00 https://biolegacyresearch.com/stakeholders-prefer-tgas-modified-approach-to-naming-biologics/ 2018-02-22T23:40:15+00:00 https://biolegacyresearch.com/fda-sponsors-seeking-qidp-fast-track-status-must-apply-for-both/ 2018-02-22T23:41:15+00:00 https://biolegacyresearch.com/fda-proposes-opioid-packaging-reductions/ 2018-02-22T23:42:01+00:00 https://biolegacyresearch.com/fda-issues-new-guidance-on-priority-review-vouchers/ 2018-02-22T23:42:46+00:00 https://biolegacyresearch.com/fda-clarifies-stance-on-clinical-trial-reimbursements/ 2018-02-22T23:43:48+00:00 https://biolegacyresearch.com/tax-reform-could-lead-to-spike-in-biopharma-ma-activity/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/women-in-biotech-underrepresented-on-boards-of-directors-across-the-bay-area/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/3-resume-tweaks-to-help-scientists-get-a-job-in-the-private-sector/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/tevas-shrinking-u-s-footprint/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/european-regulatory-committee-recommends-rejecting-puma-biotechnologys-breast-cancer-medicine/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/life-science-companies-are-litigation-targets-for-unhappy-investors/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/pfizer-receives-positive-chmp-opinion-for-two-hematology-medicines-mylotarg-and-bosulif/ 2018-02-23T00:00:00+00:00 https://biolegacyresearch.com/ema-recommends-short-physical-performance-battery-for-assessing-frailty/ 2018-02-23T22:42:34+00:00 https://biolegacyresearch.com/chmp-recommends-five-drugs-including-first-medicine-for-neonatal-diabetes/ 2018-02-23T22:43:31+00:00 https://biolegacyresearch.com/ex-horizon-exec-claims-firing-was-retaliation-for-whistleblowing-at-previous-job/ 2018-02-23T22:44:21+00:00 https://biolegacyresearch.com/fda-releases-finalized-qa-guidance-on-choosing-chemical-drug-starting-materials/ 2018-02-23T22:45:09+00:00 https://biolegacyresearch.com/truecare-biomedix-cited-for-slew-of-procedural-problems/ 2018-02-23T22:45:59+00:00 https://biolegacyresearch.com/u-k-could-seek-restitution-from-pfizer-if-legal-appeal-fails/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-yisheng-biopharmas-clinical-treatment-its-second-orphan-drug-designation/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/obseva-fertility-drug-shows-some-promise-in-late-stage-trial/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/diabetes-market-heats-up-as-eli-lillys-trulicity-combo-shows-improved-blood-sugar-control/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/european-regulators-make-decisions-on-several-companies-drugs/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/vertex-pharmaceuticals-appoints-reshma-kewalramani-as-new-cmo/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/price-of-tevas-generic-drug-to-treat-wilsons-disease-sparks-outrage/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/mylan-defeats-allergans-maneuver-to-rent-tribal-sovereign-immunity-to-avoid-restasis-patent-cha/ 2018-02-26T00:00:00+00:00 https://biolegacyresearch.com/fda-to-expand-opioid-medication-assisted-treatment-use-issue-new-draft-guidance/ 2018-02-26T22:13:37+00:00 https://biolegacyresearch.com/gottlieb-unveils-pilot-for-more-efficient-orphan-designation-requests/ 2018-02-26T22:14:00+00:00 https://biolegacyresearch.com/ptab-declares-st-regis-tribes-restasis-patent-rights-illusory/ 2018-02-26T22:17:42+00:00 https://biolegacyresearch.com/doj-files-false-claims-act-complaint-against-compounder/ 2018-02-26T22:18:37+00:00 https://biolegacyresearch.com/az-pharmaceutical-cited-for-calibration-and-batch-deficiencies/ 2018-02-26T22:19:29+00:00 https://biolegacyresearch.com/incoming-massbio-chairman-eyes-improving-gender-diversity-across-the-states-life-sciences-industry/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/aldeyra-therapeutics-inks-collaboration-deal-with-johnson-johnson-to-develop-anti-inflammatory/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/dbv-technologies-reports-positive-data-from-milk-allergy-trial/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/generation-bio-raises-100-million-series-b-to-finance-non-viral-gene-therapy-program/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/senti-biosciences-raises-53-million-from-amgen-and-others-in-series-a-financing/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/eli-lillys-verzenio-picks-up-third-approved-indication/ 2018-02-27T00:00:00+00:00 https://biolegacyresearch.com/doj-plans-opioid-task-force-and-will-join-in-multidistrict-opioid-suits/ 2018-02-27T22:47:53+00:00 https://biolegacyresearch.com/fda-considers-alternative-flu-vaccine-production-methods/ 2018-02-27T22:48:43+00:00 https://biolegacyresearch.com/pew-finds-state-oversight-of-compounders-improved-but-some-lack-inspection-resources/ 2018-02-27T22:49:37+00:00 https://biolegacyresearch.com/alchymars-warned-for-falsified-data-maintenance-issues/ 2018-02-27T22:50:42+00:00 https://biolegacyresearch.com/fda-stuns-celgene-with-refusal-to-file-letter-for-ms-treatment-ozanimod/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/inscripta-snags-55-5-million-in-funding-looks-to-expand-employment/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/life-science-community-comes-together-to-support-rare-disease-day/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/reata-pharmaceuticals-updates-data-release-dates-for-ongoing-phase-ii-trials/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/pharmacyte-presents-options-for-phase-ii-pancreatic-cancer-trial/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/galera-therapeutics-doses-first-patient-in-pancreatic-cancer-trial/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/should-biogen-buy-alkermes/ 2018-02-28T00:00:00+00:00 https://biolegacyresearch.com/drugmakers-say-guidance-on-patient-experience-data-should-cover-all-development-stages/ 2018-02-28T23:20:50+00:00 https://biolegacyresearch.com/fdas-office-of-pharmaceutical-quality-releases-first-annual-report/ 2018-02-28T23:21:42+00:00 https://biolegacyresearch.com/fda-issues-guidance-on-ich-good-clinical-practices/ 2018-02-28T23:22:28+00:00 https://biolegacyresearch.com/ema-issues-revised-guidance-on-biomarkers-diagnostic-criteria-for-alzheimers-medicines/ 2018-02-28T23:23:18+00:00 https://biolegacyresearch.com/sorrento-nabs-fda-approval-for-shingles-pain-patch-that-could-hit-blockbuster-status/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/portola-plunges-after-hint-of-delay-for-fda-approval-of-factor-xa-inhibitor/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/finch-therapeutics-raises-36-million-series-b-bringing-total-to-77-million/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/rubius-therapeutics-raises-100-million-in-crossover-financing/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/mylan-teams-up-with-revance-therapeutics-to-develop-botox-biosimilar/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/gelesis-secures-30-million-to-support-potential-approval-of-weight-loss-drug/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/u-s-department-of-justice-to-take-on-opioid-manufacturers-and-distributors/ 2018-03-01T00:00:00+00:00 https://biolegacyresearch.com/fda-releases-new-draft-guidance-on-dscsa-tracking-standards-definitions/ 2018-03-01T23:10:14+00:00 https://biolegacyresearch.com/mccaskill-bill-would-kill-tax-breaks-for-direct-to-consumer-drug-advertising/ 2018-03-01T23:11:02+00:00 https://biolegacyresearch.com/cardiologist-pleads-guilty-to-giving-aegerion-patient-information-to-boost-prescriptions/ 2018-03-01T23:11:48+00:00 https://biolegacyresearch.com/fda-issues-new-draft-guidance-for-alzheimers-trials-that-could-open-up-approvals/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/ionis-and-roche-tout-positive-data-in-early-stage-huntingtons-disease-trial/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/biogen-and-abbvie-voluntarily-pull-multiple-sclerosis-drug-off-the-market/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/meiragtx-earns-ema-prime-designation-for-achromatopsia-gene-therapy-candidate/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/opko-healths-annual-report-a-mixed-bag/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/say-no-the-right-way-how-declining-a-job-offer-can-advance-your-career/ 2018-03-02T00:00:00+00:00 https://biolegacyresearch.com/sessions-tells-dea-to-consider-lowering-opioid-production-quotas/ 2018-03-02T21:29:51+00:00 https://biolegacyresearch.com/valeant-unit-to-pay-58-million-to-settle-allegations-of-solodyn-pay-for-delay-scheme/ 2018-03-02T21:30:40+00:00 https://biolegacyresearch.com/fda-doj-file-complaint-against-arkansas-compounder-following-gmp-deviations/ 2018-03-02T21:31:30+00:00 https://biolegacyresearch.com/korean-drugmaker-draws-fda-warning-for-validation-stability-issues/ 2018-03-02T21:32:17+00:00 https://biolegacyresearch.com/vividion-therapeutics-snags-101m-from-celgene/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/unum-therapeutics-looks-to-file-ipo-reveals-patient-deaths-in-early-clinical-trial/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/prometic-snags-rare-pediatric-disease-designation-from-the-fda-for-its-inter-alpha-inhibitor-prot/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/vanda-pharmaceuticals-hetlioz-shows-promise-for-treating-jet-lag/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/dermiras-acne-medication-olumacostat-glaseretil-tanks-in-two-phase-iii-trials/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/g1-therapeutics-unveils-positive-mid-stage-data-for-myelopreservation-in-sclc-patients/ 2018-03-05T00:00:00+00:00 https://biolegacyresearch.com/oregon-bill-on-drug-transparency-heads-to-governors-desk/ 2018-03-05T23:01:36+00:00 https://biolegacyresearch.com/european-commission-clarifies-excipient-labeling-requirements/ 2018-03-05T23:02:22+00:00 https://biolegacyresearch.com/health-canada-spells-out-risk-ratings-for-gmps-in-site-inspections/ 2018-03-05T23:03:09+00:00 https://biolegacyresearch.com/kath-chemicals-cited-for-review-testing-and-cleaning-deficiencies/ 2018-03-05T23:04:43+00:00 https://biolegacyresearch.com/physician-group-releases-less-stringent-guidance-for-type-2-diabetes-care/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/fda-expands-bristol-myers-squibbs-opdivo-dosing-schedule/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/parexel-international-taps-new-ceo-jamie-macdonald/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/best-questions-to-ask-in-your-next-job-interview/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/magenta-therapeutics-and-heidelberg-pharma-team-up-for-bone-marrow-transplants/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/martin-shkreli-ordered-to-forfeit-7-36-million-in-assets-ahead-of-sentencing/ 2018-03-06T00:00:00+00:00 https://biolegacyresearch.com/dea-to-divulge-opioid-sales-data-under-confidentiality-order/ 2018-03-06T22:25:03+00:00 https://biolegacyresearch.com/fda-opioid-sales-increased-to-8-billion-from-1992-to-2015/ 2018-03-06T22:26:55+00:00 https://biolegacyresearch.com/cber-faults-drugmaker-for-implying-hemophilia-drug-allows-patients-to-engage-in-high-risk-activity/ 2018-03-06T22:28:12+00:00 https://biolegacyresearch.com/chinese-drugmaker-warned-for-testing-deficiencies/ 2018-03-06T22:29:00+00:00 https://biolegacyresearch.com/esperions-cholesterol-drug-positive-in-phiii-trial/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/roivant-licenses-diabetes-drug-from-ligand-pharma/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/fda-greenlights-new-treatment-for-multi-drug-resistant-hiv-1/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/seattle-genetics-commences-dosing-in-early-stage-multiple-myeloma-trial/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/fda-approves-23andmes-direct-to-consumer-genetic-test-for-cancer/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/modernas-vaccines-boss-leaves-company/ 2018-03-07T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-says-contracting-system-is-rigged-against-biosimilars/ 2018-03-07T23:02:50+00:00 https://biolegacyresearch.com/chicago-sues-opioid-distributors-as-mccaskill-accuses-teva-of-stonewalling-investigation/ 2018-03-07T23:03:43+00:00 https://biolegacyresearch.com/former-fda-official-shares-tips-for-data-integrity-compliance/ 2018-03-07T23:07:04+00:00 https://biolegacyresearch.com/clinical-trial-startup-process-takes-longer-than-10-years-ago-tufts-csdd-reports/ 2018-03-07T23:07:53+00:00 https://biolegacyresearch.com/prevail-therapeutics-grabs-75-million-to-advance-parkinsons-disease-programs/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/evotec-and-sanofi-collaborate-on-infectious-disease-rd-initiative/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/cyteir-therapeutics-nabs-29-million-and-a-new-ceo/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/pfizer-terminates-pdc-agreement-with-cytomx-therapeutics/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/roches-john-reed-is-stepping-down/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/health-insurer-cigna-paying-67-billion-to-buy-express-script/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/juno-therapeutics-spinout-raises-90m/ 2018-03-08T00:00:00+00:00 https://biolegacyresearch.com/health-canada-to-provide-assistance-for-smes-to-meet-mdsap-deadline/ 2018-03-08T22:24:36+00:00 https://biolegacyresearch.com/india-releases-final-audit-fees-for-notified-bodies/ 2018-03-08T22:25:27+00:00 https://biolegacyresearch.com/regulatory-hurdles-for-design-changes-stall-boston-scientifics-comeback/ 2018-03-08T22:26:17+00:00 https://biolegacyresearch.com/china-fda-to-issue-new-device-standards-over-next-two-years/ 2018-03-08T22:27:23+00:00 https://biolegacyresearch.com/fda-cites-digital-heat-for-failing-to-establish-design-procedures-capa/ 2018-03-08T22:28:14+00:00 https://biolegacyresearch.com/fda-warns-german-device-firm-over-lack-of-procedures/ 2018-03-08T22:29:15+00:00 https://biolegacyresearch.com/fda-flags-repeat-nonconformities-at-zimmer-biomet-facility/ 2018-03-08T22:30:17+00:00 https://biolegacyresearch.com/brazil-clarifies-anvisa-oversight-roles-for-devices/ 2018-03-08T22:31:27+00:00 https://biolegacyresearch.com/zoll-draws-form-483-for-environmental-control-problems-complaint-files/ 2018-03-08T22:32:26+00:00 https://biolegacyresearch.com/pacific-hospital-supply-warned-for-validation-process-control-issues/ 2018-03-08T22:33:22+00:00 https://biolegacyresearch.com/gottlieb-marks-explore-regulatory-pathways-for-stem-cell-development/ 2018-03-08T22:55:00+00:00 https://biolegacyresearch.com/no-safety-risk-in-switching-from-reference-drugs-to-biosimilars-study-finds/ 2018-03-08T22:56:00+00:00 https://biolegacyresearch.com/fda-advisory-panel-recommends-10mg-xeljanz-dosing-regimen/ 2018-03-08T22:56:02+00:00 https://biolegacyresearch.com/abiomed-will-pay-3-1-million-to-settle-kickback-allegations/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/myokardia-sees-positive-results-in-mid-stage-heart-trial/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/xeris-raises-55m-for-glucagon-rescue-pen/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/acelrx-pharma-plans-to-resubmit-new-drug-application-for-dsuvia/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/voyager-therapeutics-parkinsons-trial-shows-positive-results/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/9-signs-its-time-to-find-a-new-job/ 2018-03-09T00:00:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-five-firms-warned-for-sanitation-procedural-issues/ 2018-03-09T20:20:53+00:00 https://biolegacyresearch.com/483-roundup-four-manufacturers-cited-for-cleaning-sanitation-issues/ 2018-03-09T20:21:52+00:00 https://biolegacyresearch.com/fda-regs-plunged-in-2017-but-other-developments-built-on-trends/ 2018-03-09T20:23:00+00:00 https://biolegacyresearch.com/fda-says-most-accelerated-oncology-approvals-went-on-to-prove-clinical-benefit/ 2018-03-09T22:50:32+00:00 https://biolegacyresearch.com/prac-recommends-contraindication-for-zytiga-and-xofigo/ 2018-03-09T22:51:24+00:00 https://biolegacyresearch.com/aam-perrigo-urge-fda-to-clarify-anda-submission-guidance/ 2018-03-09T22:52:12+00:00 https://biolegacyresearch.com/hong-kong-firm-draws-warning-for-testing-labeling-deficiencies/ 2018-03-09T22:53:03+00:00 https://biolegacyresearch.com/biogen-buys-pfizers-phii-ready-schizophrenia-asset/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/sarepta-to-seek-fda-approval-for-second-dmd-treatment/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/anti-obesity-drugmaker-orexigen-therapeutics-files-for-bankruptcy/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/realm-therapeutics-flunks-phii-trial-for-conjunctivitis-drug/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/merrimack-pharmaceuticals-expands-phase-ii-lung-cancer-study/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/immutep-strikes-deal-with-merck-to-pair-product-with-keytruda-in-phase-ii-trial/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/hikmas-advair-generic-gets-further-delayed/ 2018-03-12T00:00:00+00:00 https://biolegacyresearch.com/1200-xarelto-liability-cases-to-be-selected-for-trial-over-the-next-six-months/ 2018-03-12T21:35:24+00:00 https://biolegacyresearch.com/fda-generic-drug-approvals-remain-low-in-february/ 2018-03-12T21:36:00+00:00 https://biolegacyresearch.com/impax-labs-settles-portion-of-solodyn-pay-for-delay-cases-for-35-million-as-trial-begins/ 2018-03-12T21:37:30+00:00 https://biolegacyresearch.com/doj-official-departments-opioids-strategy-will-include-aggressive-fca-enforcement/ 2018-03-12T21:38:00+00:00 https://biolegacyresearch.com/abbvies-elagolix-dazzles-in-phase-iii-trial/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/protalix-biotherapeutics-treatment-for-ulcerative-colitis-shows-positive-data/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/proteostasis-therapeutics-snags-breakthrough-designation/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/are-life-science-companies-falling-behind-tech-companies/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-mercks-keytruda-priority-review-for-cervical-cancer/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/aeglea-biotherapeutics-updates-phase-iii-trial-data/ 2018-03-13T00:00:00+00:00 https://biolegacyresearch.com/fda-plans-more-research-into-drug-advertising/ 2018-03-13T21:57:41+00:00 https://biolegacyresearch.com/fda-adopts-final-ich-m7r1-mutagenic-carcinogen-guideline/ 2018-03-13T21:58:50+00:00 https://biolegacyresearch.com/presidents-panel-calls-for-value-based-pricing-increased-competition-to-lower-cancer-drug-prices/ 2018-03-13T21:59:42+00:00 https://biolegacyresearch.com/european-commission-finds-fewer-pay-for-delay-deals/ 2018-03-13T22:00:57+00:00 https://biolegacyresearch.com/right-to-try-drug-bill-defeated-in-house/ 2018-03-14T00:00:00+00:00 https://biolegacyresearch.com/crinetics-pharmaceuticals-snags-63-5-million-in-series-b-funding/ 2018-03-14T00:00:00+00:00 https://biolegacyresearch.com/foghorn-therapeutics-launches-with-50-million/ 2018-03-14T00:00:00+00:00 https://biolegacyresearch.com/auris-medical-fails-again-in-phase-iii-trial/ 2018-03-14T00:00:00+00:00 https://biolegacyresearch.com/pharmajet-releases-positive-phase-i-results-for-hantavirus-vaccines/ 2018-03-14T00:00:00+00:00 https://biolegacyresearch.com/house-fails-to-pass-new-version-of-right-to-try-legislation/ 2018-03-14T23:30:39+00:00 https://biolegacyresearch.com/bipartisan-bill-would-allow-dea-to-factor-overdoses-public-health-into-opioid-quotas/ 2018-03-14T23:31:37+00:00 https://biolegacyresearch.com/court-rules-walgreens-must-face-most-claims-in-generics-overcharging-class-action/ 2018-03-14T23:32:28+00:00 https://biolegacyresearch.com/mhra-issues-new-guidance-on-gxp-data-integrity-compliance/ 2018-03-14T23:33:43+00:00 https://biolegacyresearch.com/tga-announces-overhaul-of-drug-advertising-regulations/ 2018-03-14T23:34:37+00:00 https://biolegacyresearch.com/theranos-elizabeth-holmes-charged-with-fraud/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-gets-another-shot-at-fda-approval-for-ra-drug/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/ideaya-biosciences-nabs-94-million/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/consolidation-could-be-coming-to-pharma-industry/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/is-celgene-considering-going-private/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/fda-slaps-clinical-hold-on-solid-bioscience-dmd-gene-therapy-program/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/ionis-pharmaceuticals-partners-with-akcea-therapeutics-in-a-potential-1-7-billion-deal/ 2018-03-15T00:00:00+00:00 https://biolegacyresearch.com/public-citizen-flags-sharp-decline-in-penalties-against-pharma/ 2018-03-15T21:17:57+00:00 https://biolegacyresearch.com/judge-orders-class-action-against-cigna-to-proceed/ 2018-03-15T21:57:04+00:00 https://biolegacyresearch.com/senate-help-committee-considers-340b-programs-goals/ 2018-03-15T21:59:06+00:00 https://biolegacyresearch.com/fda-accepting-public-comments-for-adverse-event-reporting-submission-forms/ 2018-03-15T22:06:52+00:00 https://biolegacyresearch.com/arbor-biotechnologies-comes-out-of-stealth-mode/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/theranos-serves-as-a-cautionary-tale-for-biotech-funding/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/fda-gives-go-ahead-for-tetras-phase-ii-trial/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/what-astronaut-peggy-whitson-can-teach-us-about-rejection-in-the-workplace/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-selling-lifescan-unit-for-2-1-billion/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/amo-pharma-sees-positive-results-in-phase-ii-trials/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/adaptimmune-sees-positive-early-results-in-cancer-treatment/ 2018-03-16T00:00:00+00:00 https://biolegacyresearch.com/new-analysis-says-payments-from-opioid-makers-increase-doctors-likelihood-to-prescribe-them/ 2018-03-16T21:27:45+00:00 https://biolegacyresearch.com/ag-sessions-lexington-speech-outlines-new-initiatives-to-combat-opioid-crisis/ 2018-03-16T21:28:40+00:00 https://biolegacyresearch.com/french-drug-contract-tester-warned-for-gmp-violations/ 2018-03-16T21:29:46+00:00 https://biolegacyresearch.com/fda-hits-terra-biological-over-misbranding/ 2018-03-16T21:30:44+00:00 https://biolegacyresearch.com/alzheon-launches-ipo-to-fund-alzheimers-drug/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/heron-therapeutics-soars-on-positive-phase-iii-results/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/denali-therapeutics-adds-155-million-from-takeda/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/study-reveals-huge-potential-for-mrna-drug-targets/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/cidara-touts-positive-phase-ii-antifungal-data/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/new-study-indicates-dna-plays-role-in-gender-identity/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/6-biotech-companies-with-upside-potential/ 2018-03-19T00:00:00+00:00 https://biolegacyresearch.com/trump-targets-overprescribing-addictiveness-of-opioids-at-new-england-rally/ 2018-03-19T21:22:28+00:00 https://biolegacyresearch.com/massachusetts-court-rules-merck-can-be-sued-for-inadequate-labeling-of-generics/ 2018-03-19T21:23:00+00:00 https://biolegacyresearch.com/u-s-attorney-charges-five-doctors-with-taking-bribes-kickbacks-from-insys-to-prescribe-fentanyl/ 2018-03-19T21:24:00+00:00 https://biolegacyresearch.com/fda-releases-first-clinical-study-summary-in-new-transparency-pilot/ 2018-03-19T21:39:38+00:00 https://biolegacyresearch.com/astrazeneca-shows-off-new-farxiga-data-for-diabetes-patients-with-chronic-kidney-disease/ 2018-03-20T00:00:00+00:00 https://biolegacyresearch.com/fda-grants-priority-review-for-prostrate-cancer-treatment/ 2018-03-20T00:00:00+00:00 https://biolegacyresearch.com/can-gilead-develop-a-cure-for-hiv/ 2018-03-20T00:00:00+00:00 https://biolegacyresearch.com/arena-pharmaceuticals-shares-explode-on-positive-ulcerative-colitis-trial-data/ 2018-03-20T00:00:00+00:00 https://biolegacyresearch.com/ocugens-dry-eye-treatment-hit-its-primary-endpoint/ 2018-03-20T00:00:00+00:00 https://biolegacyresearch.com/fda-postpones-enforcement-of-combination-product-rules-outlines-requirements-for-constituent-parts/ 2018-03-20T19:56:45+00:00 https://biolegacyresearch.com/ec-committee-members-propose-overhaul-of-otc-monograph-system/ 2018-03-20T19:57:28+00:00 https://biolegacyresearch.com/abilify-lawsuits-set-for-first-trials-in-june/ 2018-03-20T19:58:18+00:00 https://biolegacyresearch.com/indian-api-manufacturer-warned-for-serious-gmp-violations/ 2018-03-20T19:59:10+00:00 https://biolegacyresearch.com/celgene-partners-with-prothena-therapeutics-in-potential-2b-deal/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-is-taking-a-tough-approach-to-budgets/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/seattle-genetics-gains-another-fda-approval/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/is-there-a-biotech-bubble-brewing-in-boston/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/tcr2-therapeutics-snags-125-million-to-expand-t-cell-program/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/alder-ceo-is-stepping-down/ 2018-03-21T00:00:00+00:00 https://biolegacyresearch.com/fda-clarifies-informal-feedback-process-prior-to-marketing-decisions/ 2018-03-21T21:11:23+00:00 https://biolegacyresearch.com/developers-voice-concern-over-draft-orphan-drug-loophole-guidance/ 2018-03-21T21:14:56+00:00 https://biolegacyresearch.com/phrma-and-bio-say-european-proposals-hurt-patent-rights/ 2018-03-21T21:16:01+00:00 https://biolegacyresearch.com/ema-issues-guidance-on-biomarkers-criteria-for-alzheimers-medicines/ 2018-03-21T21:17:20+00:00 https://biolegacyresearch.com/state-oversight-of-compounders-improved-but-some-lack-resources/ 2018-03-21T21:18:47+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-chemical-drug-starting-materials/ 2018-03-21T21:23:25+00:00 https://biolegacyresearch.com/gottlieb-testifies-at-ec-committee-hearing-on-initiatives-to-fight-opioid-crisis/ 2018-03-21T21:49:15+00:00 https://biolegacyresearch.com/industry-group-sues-hhs-for-applying-medicaid-rebate-rule-to-radiopharmaceutical-drugs/ 2018-03-21T21:50:22+00:00 https://biolegacyresearch.com/judge-partially-dismisses-ftc-complaint-alleging-shire-used-fraudulent-petitions-to-stifle-generics/ 2018-03-21T21:51:14+00:00 https://biolegacyresearch.com/labocont-draws-warning-letter-for-gmp-violations/ 2018-03-21T21:52:07+00:00 https://biolegacyresearch.com/poor-mid-stage-results-sink-abbvies-plans-for-cancer-drug/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/rheos-medicines-launches-with-60-million/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/u-s-house-passes-right-to-try-legislation-on-second-attempt/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/gsk-is-now-favorite-to-acquire-pfizers-consumer-health-business/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/array-biopharma-touts-phase-iii-results-for-melanoma-therapy/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/arena-pharma-raising-352-million-following-positive-phase-ii-data/ 2018-03-22T00:00:00+00:00 https://biolegacyresearch.com/omnibus-spending-bill-hikes-fda-funding-by-135-million/ 2018-03-22T22:12:00+00:00 https://biolegacyresearch.com/house-republicans-send-right-to-try-bill-to-the-senate/ 2018-03-22T22:13:43+00:00 https://biolegacyresearch.com/endo-watson-teikoku-to-pay-270-million-to-settle-lidoderm-pay-for-delay-suits/ 2018-03-22T22:15:16+00:00 https://biolegacyresearch.com/german-biotech-morphosys-seeks-nasdaq-listing/ 2018-03-23T00:00:00+00:00 https://biolegacyresearch.com/gsk-walks-away-from-acquiring-pfizer-consumer-goods-unit/ 2018-03-23T00:00:00+00:00 https://biolegacyresearch.com/akebia-announces-85m-public-offering/ 2018-03-23T00:00:00+00:00 https://biolegacyresearch.com/pharma-execs-are-attractive-candidates-for-healthcare-leadership-roles/ 2018-03-23T00:00:00+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-on-clinical-need-test-for-bulk-substances-used-in-compounding/ 2018-03-23T21:25:41+00:00 https://biolegacyresearch.com/fda-previews-pilot-program-to-provide-early-regulatory-review-of-innovative-trial-designs/ 2018-03-23T21:26:00+00:00 https://biolegacyresearch.com/chmp-endorses-six-medicines-for-approval-at-march-meeting/ 2018-03-23T21:27:36+00:00 https://biolegacyresearch.com/kolmar-korea-cited-for-slew-of-violations/ 2018-03-23T21:28:53+00:00 https://biolegacyresearch.com/ablynx-drug-fails-again-in-mid-stage-trial/ 2018-03-26T00:00:00+00:00 https://biolegacyresearch.com/stock-plunges-despite-biohavens-positive-migraine-data/ 2018-03-26T00:00:00+00:00 https://biolegacyresearch.com/immunogen-stock-climbs-on-positive-ovarian-cancer-data/ 2018-03-26T00:00:00+00:00 https://biolegacyresearch.com/protagonist-craters-after-discontinuing-phase-iib-ulcerative-colitis-study/ 2018-03-26T00:00:00+00:00 https://biolegacyresearch.com/allecra-therapeutics-new-antibiotic-shows-promise-for-resistant-bacterial-infections/ 2018-03-26T00:00:00+00:00 https://biolegacyresearch.com/sen-mccaskill-prices-for-top-20-branded-drugs-for-seniors-spiked-10-times-faster-than-inflation/ 2018-03-26T21:49:21+00:00 https://biolegacyresearch.com/fda-releases-guidance-for-using-copd-outcome-assessment-tool/ 2018-03-26T21:53:38+00:00 https://biolegacyresearch.com/phrma-drugmakers-find-duplicative-requirements-in-cmc-biologics-guidance/ 2018-03-26T21:54:41+00:00 https://biolegacyresearch.com/delaware-court-rules-against-indivior-in-suboxone-patent-case/ 2018-03-26T21:56:32+00:00 https://biolegacyresearch.com/indian-drugmaker-cited-for-numerous-violations/ 2018-03-26T21:57:32+00:00 https://biolegacyresearch.com/fda-committee-recommends-approval-of-opioid-withdrawal-drug/ 2018-03-27T21:37:10+00:00 https://biolegacyresearch.com/sen-alexander-proposes-bills-to-increase-fda-options-to-tackle-opioid-crisis/ 2018-03-27T21:38:07+00:00 https://biolegacyresearch.com/abbvie-must-pay-3-million-in-retrial-of-first-androgel-bellwether-suit/ 2018-03-27T21:39:07+00:00 https://biolegacyresearch.com/fda-warns-two-compounders-for-adulterated-products/ 2018-03-27T21:40:11+00:00 https://biolegacyresearch.com/florida-company-sidelined-after-selling-unapproved-drugs/ 2018-03-28T21:53:48+00:00 https://biolegacyresearch.com/tampa-firm-warned-for-investigational-procedural-issues/ 2018-03-28T21:54:38+00:00 https://biolegacyresearch.com/allerquest-cited-for-sterility-air-control-concerns/ 2018-03-28T21:55:27+00:00 https://biolegacyresearch.com/amgen-asks-if-drug-suffixes-for-biologics-and-biosimilars-could-lead-to-misbranding-charges/ 2018-03-28T21:58:11+00:00 https://biolegacyresearch.com/fda-issues-first-required-inspections-report-covering-2017/ 2018-03-28T21:59:32+00:00 https://biolegacyresearch.com/oig-fda-must-increase-education-outreach-to-pharmacies-on-drug-tracing-requirements/ 2018-03-29T21:20:21+00:00 https://biolegacyresearch.com/gao-fdas-monitoring-of-early-abortion-drug-does-not-raise-safety-concerns/ 2018-03-29T21:21:17+00:00 https://biolegacyresearch.com/judge-strikes-235-million-patent-infringement-verdict-against-teva/ 2018-03-29T21:22:08+00:00 https://biolegacyresearch.com/gottlieb-stresses-importance-of-patient-voice-in-benefit-risk-assessments/ 2018-03-30T21:19:46+00:00 https://biolegacyresearch.com/impax-reaches-20-million-midtrial-settlement-with-retailers-over-pay-for-delay-allegations/ 2018-03-30T21:20:36+00:00 https://biolegacyresearch.com/appeals-court-stays-ptab-review-over-allerganst-regis-patent-deal/ 2018-03-30T21:21:25+00:00 https://biolegacyresearch.com/dr-reddys-hit-with-483-for-supplier-quality-agreements-capa-issues/ 2018-03-30T21:22:21+00:00 https://biolegacyresearch.com/fda-details-how-fy-2019-funds-will-be-spent/ 2018-04-02T22:09:11+00:00 https://biolegacyresearch.com/industry-groups-urge-fda-to-better-define-terms-in-supply-chain-security-guidance/ 2018-04-02T22:10:22+00:00 https://biolegacyresearch.com/fda-should-allow-reciprocal-approval-for-generic-drugs-to-reduce-prices-increase-availability/ 2018-04-02T22:11:14+00:00 https://biolegacyresearch.com/vertice-petitions-for-change-in-bioequivalence-guidance-requirements/ 2018-04-02T22:12:09+00:00 https://biolegacyresearch.com/chinas-fda-restructured-under-a-new-regulatory-authority/ 2018-04-03T21:24:00+00:00 https://biolegacyresearch.com/senators-request-tri-source-justify-1400-percent-price-hikes-for-cancer-drug/ 2018-04-03T21:24:59+00:00 https://biolegacyresearch.com/wisconsin-west-virginia-pass-biosimilar-substitution-laws/ 2018-04-03T21:25:48+00:00 https://biolegacyresearch.com/ema-plans-to-revise-gmp-non-compliance-reports-to-help-deal-with-possible-shortages/ 2018-04-03T21:26:36+00:00 https://biolegacyresearch.com/prac-requests-supplementary-info-from-antiretrovirals-related-to-autoimmune-hepatitis/ 2018-04-03T21:27:36+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-liposome-drug-products/ 2018-04-04T21:40:00+00:00 https://biolegacyresearch.com/trump-administrations-china-tariffs-hit-drug-products-ingredients/ 2018-04-04T21:40:00+00:00 https://biolegacyresearch.com/heal-opioid-initiative-stresses-non-opioid-therapies-and-reducing-overprescription/ 2018-04-04T21:42:03+00:00 https://biolegacyresearch.com/osiris-sues-mimedx-alleging-theft-of-customers-trade-secrets/ 2018-04-04T21:43:06+00:00 https://biolegacyresearch.com/gottlieb-calls-for-isps-social-media-to-confront-illegal-opioid-sellers/ 2018-04-04T21:50:01+00:00 https://biolegacyresearch.com/states-feds-sue-mckesson-for-repackaging-oncology-drug-overfill/ 2018-04-05T21:44:16+00:00 https://biolegacyresearch.com/india-to-mandate-drug-manufacturers-inclusion-in-new-national-database/ 2018-04-05T21:45:17+00:00 https://biolegacyresearch.com/fda-seeks-industry-feedback-on-industry-barriers-to-exposure-response-analyses/ 2018-04-05T21:46:19+00:00 https://biolegacyresearch.com/china-announces-new-moves-to-boost-generic-drugs/ 2018-04-05T21:47:39+00:00 https://biolegacyresearch.com/fda-outlines-considerations-for-enrolling-pregnant-women-in-clinical-trials/ 2018-04-06T21:27:25+00:00 https://biolegacyresearch.com/celltrion-receives-complete-response-letters-for-two-biosimilars/ 2018-04-06T21:28:24+00:00 https://biolegacyresearch.com/health-canada-adopts-ich-guidelines-for-drug-substances-residual-solvents/ 2018-04-06T21:29:11+00:00 https://biolegacyresearch.com/fda-warns-biotek-for-marketing-misbranded-drugs-gmp-violations/ 2018-04-06T21:29:55+00:00 https://biolegacyresearch.com/fda-opened-record-number-of-fraud-investigations-in-fiscal-2017/ 2018-04-09T21:34:17+00:00 https://biolegacyresearch.com/fda-recommends-early-pre-approval-trials-in-pediatrics-for-systemic-dermatitis-drugs/ 2018-04-09T21:35:08+00:00 https://biolegacyresearch.com/cder-issues-mapp-on-parenteral-drugs-in-plastic-immediate-containers/ 2018-04-09T21:36:19+00:00 https://biolegacyresearch.com/advocacy-groups-appeal-to-hhs-to-claim-patents-and-negotiate-lower-drug-prices/ 2018-04-09T21:37:47+00:00 https://biolegacyresearch.com/spending-bill-raises-medical-product-safety-funding-by-113-2-million/ 2018-04-10T20:41:36+00:00 https://biolegacyresearch.com/warning-letter-roundup-five-firms-draw-letters-for-faulty-procedures/ 2018-04-10T20:43:22+00:00 https://biolegacyresearch.com/483-roundup-five-firms-flagged-for-training-other-violations/ 2018-04-10T20:44:31+00:00 https://biolegacyresearch.com/fda-freezes-enforcement-of-combination-product-rules/ 2018-04-10T20:45:31+00:00 https://biolegacyresearch.com/report-top-drugmakers-put-tax-savings-toward-stock-buybacks-not-lower-prices/ 2018-04-10T21:49:34+00:00 https://biolegacyresearch.com/fda-adopts-ich-update-to-17-year-old-pediatric-clinical-trial-guideline/ 2018-04-10T21:50:18+00:00 https://biolegacyresearch.com/senators-ask-white-house-for-update-on-opioid-commission-recommendations/ 2018-04-10T21:51:07+00:00 https://biolegacyresearch.com/fda-denies-insys-petition-on-stricter-requirements-for-syndros-generics/ 2018-04-10T21:51:52+00:00 https://biolegacyresearch.com/tris-pharma-slammed-for-adulterated-products/ 2018-04-10T21:53:09+00:00 https://biolegacyresearch.com/fda-to-consider-mapping-of-iso-13485/ 2018-04-11T21:25:00+00:00 https://biolegacyresearch.com/health-canada-reclassifies-sterilant-solutions-disinfectants-as-devices/ 2018-04-11T21:27:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-fda-warns-five-firms-for-quality-issues/ 2018-04-11T21:31:00+00:00 https://biolegacyresearch.com/fda-postpones-enforcement-of-combination-product-rules/ 2018-04-11T21:33:43+00:00 https://biolegacyresearch.com/alere-settles-false-claims-suit-for-33-2-million/ 2018-04-11T21:34:30+00:00 https://biolegacyresearch.com/gudid-database-contains-mostly-class-ii-and-implantable-devices/ 2018-04-11T21:35:19+00:00 https://biolegacyresearch.com/483-roundup-fda-hits-facilities-for-inadequate-capas-investigations/ 2018-04-11T21:36:13+00:00 https://biolegacyresearch.com/china-fda-releases-draft-guidance-on-udis/ 2018-04-11T21:37:08+00:00 https://biolegacyresearch.com/lawmaker-raises-conflict-of-interest-concerns-over-drug-pricing-advisor/ 2018-04-11T21:53:38+00:00 https://biolegacyresearch.com/patient-advocates-request-public-hearing-to-examine-court-ordered-drug-restrictions/ 2018-04-11T21:54:27+00:00 https://biolegacyresearch.com/eu-reallocates-uks-centrally-authorized-medical-product-portfolio/ 2018-04-11T21:55:24+00:00 https://biolegacyresearch.com/pfizer-subsidiary-cited-for-employee-training-sample-inspections/ 2018-04-11T21:56:07+00:00 https://biolegacyresearch.com/judge-orders-dea-to-produce-data-on-suspicious-opioid-orders/ 2018-04-12T21:47:32+00:00 https://biolegacyresearch.com/api-manufacturer-flagged-for-quality-investigational-issues/ 2018-04-12T21:48:28+00:00 https://biolegacyresearch.com/emas-international-inspection-program-reports-increased-data-sharing/ 2018-04-12T21:52:52+00:00 https://biolegacyresearch.com/whistleblower-mallinckrodt-concealed-vital-information-to-drive-acthar-sales/ 2018-04-12T21:54:08+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-for-special-protocol-assessments/ 2018-04-13T21:42:22+00:00 https://biolegacyresearch.com/marylands-generic-drug-pricing-law-struck-down-by-federal-court/ 2018-04-13T21:43:07+00:00 https://biolegacyresearch.com/gao-federal-agencies-need-performance-based-measures-to-judge-opioid-strategies/ 2018-04-13T21:43:52+00:00 https://biolegacyresearch.com/lannett-petitions-for-stay-of-glycolax-withdrawal-order/ 2018-04-13T21:44:35+00:00 https://biolegacyresearch.com/fda-to-launch-pilot-program-on-model-informed-drug-development/ 2018-04-16T21:58:17+00:00 https://biolegacyresearch.com/fda-retracts-refuse-to-file-letter-sent-to-alkermes-in-march/ 2018-04-16T21:59:04+00:00 https://biolegacyresearch.com/vivli-beta-tests-clinical-trial-data-sharing-platform/ 2018-04-16T21:59:54+00:00 https://biolegacyresearch.com/fda-cites-optikem-for-unsanitary-conditions-lack-of-records/ 2018-04-16T22:00:00+00:00 https://biolegacyresearch.com/gottlieb-discusses-fda-budget-plans-in-appropriations-hearing/ 2018-04-17T21:50:12+00:00 https://biolegacyresearch.com/proposed-continuous-manufacturing-legislation-would-pair-universities-with-fda-industry/ 2018-04-17T21:51:43+00:00 https://biolegacyresearch.com/senate-bill-seeks-to-speed-fast-track-options-for-opioid-alternatives/ 2018-04-17T21:52:30+00:00 https://biolegacyresearch.com/u-k-firm-hit-for-process-validation-quality-control-shortcomings/ 2018-04-17T21:53:18+00:00 https://biolegacyresearch.com/fda-releases-guidance-on-quality-considerations-for-inhaled-drugs/ 2018-04-18T22:00:45+00:00 https://biolegacyresearch.com/pace-of-fda-generic-approvals-sharply-increases-in-march/ 2018-04-18T22:01:29+00:00 https://biolegacyresearch.com/dea-proposes-to-consider-diversion-data-in-setting-opioid-quotas/ 2018-04-18T22:02:14+00:00 https://biolegacyresearch.com/sanders-legislation-targets-drugmakers-involved-in-opioid-epidemic/ 2018-04-18T22:03:10+00:00 https://biolegacyresearch.com/court-revives-gsk-lawsuit-finding-non-english-speaking-plaintiffs-may-not-have-been-told-drugs-risks/ 2018-04-18T22:04:00+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-api-good-manufacturing-practices-guidelines/ 2018-04-19T21:44:07+00:00 https://biolegacyresearch.com/fda-advisory-committee-recommends-approval-for-cannabis-derived-treatment-for-epilepsy/ 2018-04-19T21:45:27+00:00 https://biolegacyresearch.com/senators-ask-azar-to-negotiate-lower-prices-for-opioid-overdose-drug/ 2018-04-19T21:46:24+00:00 https://biolegacyresearch.com/hhs-proposes-common-rule-delay-but-certain-research-provisions-may-be-allowed/ 2018-04-20T21:41:05+00:00 https://biolegacyresearch.com/fda-guidance-calls-for-novel-endpoints-in-buprenorphine-clinical-trials/ 2018-04-20T21:41:58+00:00 https://biolegacyresearch.com/pbms-may-be-complicit-in-schemes-to-curb-price-competition-gottlieb-says/ 2018-04-20T21:42:42+00:00 https://biolegacyresearch.com/nihs-heal-initiative-reverses-course-and-will-refuse-private-funding/ 2018-04-20T21:43:29+00:00 https://biolegacyresearch.com/generics-spending-declined-in-2017-iqvia-reports/ 2018-04-20T21:44:23+00:00 https://biolegacyresearch.com/fda-issues-streamlined-nonclinical-trial-guidance-for-hematologic-disorder-drugs/ 2018-04-23T22:16:58+00:00 https://biolegacyresearch.com/fda-committee-votes-in-favor-of-arthritis-drugs-efficacy-splits-on-safety-and-risk-benefit-profile/ 2018-04-23T22:18:09+00:00 https://biolegacyresearch.com/cber-issues-guidance-on-datasets-for-vaccine-applications/ 2018-04-23T22:18:58+00:00 https://biolegacyresearch.com/fda-calls-for-more-data-in-pfizers-herceptin-biosimilar-application/ 2018-04-23T22:19:45+00:00 https://biolegacyresearch.com/gottlieb-flags-fdas-plans-for-generics-in-senate-appropriations-hearing/ 2018-04-24T22:05:24+00:00 https://biolegacyresearch.com/senate-help-committee-advances-opioid-crisis-bill-without-tougher-drugmaker-penalties/ 2018-04-24T22:06:12+00:00 https://biolegacyresearch.com/cder-updates-policies-on-expedited-review-of-prior-approval-supplements/ 2018-04-24T22:06:57+00:00 https://biolegacyresearch.com/teamsters-sue-drugmakers-distributors-pbms-over-opioids/ 2018-04-24T22:07:42+00:00 https://biolegacyresearch.com/supreme-court-rules-inter-partes-review-procedure-constitutional/ 2018-04-25T21:45:48+00:00 https://biolegacyresearch.com/fda-extends-electronic-submission-deadline-for-type-iii-drug-master-files/ 2018-04-25T21:46:56+00:00 https://biolegacyresearch.com/joint-advisory-committee-votes-celebrex-trial-demonstrated-safety/ 2018-04-25T21:47:50+00:00 https://biolegacyresearch.com/uk-plans-to-stick-with-eu-clinical-trial-regulations-post-brexit/ 2018-04-25T21:48:37+00:00 https://biolegacyresearch.com/fda-issues-final-guidance-on-imaging-based-clinical-trial-endpoints/ 2018-04-26T21:16:00+00:00 https://biolegacyresearch.com/pharma-companies-ask-for-more-clarity-in-ich-e9-addendum/ 2018-04-26T21:17:33+00:00 https://biolegacyresearch.com/fda-warns-degasa-over-water-system-insufficient-microbial-testing/ 2018-04-26T21:18:26+00:00 https://biolegacyresearch.com/teamsters-question-mckesson-executives-role-in-opioid-epidemic/ 2018-04-27T21:45:00+00:00 https://biolegacyresearch.com/appeals-court-upholds-mercks-unclean-hands-verdict/ 2018-04-27T21:45:01+00:00 https://biolegacyresearch.com/chinese-api-manufacturer-draws-warning-over-data-management/ 2018-04-27T21:46:33+00:00 https://biolegacyresearch.com/emas-chmp-recommends-three-drugs-at-april-meeting/ 2018-04-27T21:53:34+00:00 https://biolegacyresearch.com/u-s-pharmacopeia-drops-biologics-naming-proposal/ 2018-04-30T22:16:03+00:00 https://biolegacyresearch.com/u-s-trade-rep-places-canada-on-priority-watch-list-over-drug-policies/ 2018-04-30T22:17:06+00:00 https://biolegacyresearch.com/fda-ad-and-promo-enforcement-targets-presentation-of-risk-info-pre-approval-promotions/ 2018-04-30T22:18:01+00:00 https://biolegacyresearch.com/ema-issues-qa-on-health-based-exposure-limits-and-prevention-of-cross-contamination/ 2018-04-30T22:22:24+00:00 https://biolegacyresearch.com/judge-rules-biogen-must-face-federal-portion-of-fca-complaint/ 2018-04-30T22:23:16+00:00 https://biolegacyresearch.com/fda-advisory-committee-signs-off-on-risk-benefit-profile-of-sigas-smallpox-nda/ 2018-05-01T22:02:00+00:00 https://biolegacyresearch.com/sanofi-regeneron-to-cut-cholesterol-drug-price-in-exchange-for-inclusion-on-express-script-plan/ 2018-05-01T22:04:10+00:00 https://biolegacyresearch.com/u-s-appellate-judge-sides-with-broad-institute-in-crispr-patent-case/ 2018-05-01T22:05:13+00:00 https://biolegacyresearch.com/fda-warns-fusion-iv-over-labeling-compounding-issues/ 2018-05-01T22:06:03+00:00 https://biolegacyresearch.com/final-guidance-on-pdufa-vi-explains-changes-to-structure-and-fee-types/ 2018-05-02T21:39:32+00:00 https://biolegacyresearch.com/achaogen-drug-gets-split-decision-on-safety-and-effectiveness-for-utis-bloodstream-infections/ 2018-05-02T21:40:37+00:00 https://biolegacyresearch.com/fresenius-claims-blatant-fraud-at-akorn-led-it-to-scuttle-merger/ 2018-05-02T21:41:32+00:00 https://biolegacyresearch.com/abbvie-cited-over-complaint-handling-product-sampling/ 2018-05-02T21:42:24+00:00 https://biolegacyresearch.com/gottlieb-says-feds-will-target-drug-rebates/ 2018-05-03T21:38:14+00:00 https://biolegacyresearch.com/expert-group-says-infocare-drugs-risk-benefit-profile-does-not-support-approval/ 2018-05-03T21:39:34+00:00 https://biolegacyresearch.com/ema-conducting-fewer-gmp-but-more-gcp-and-pharmacovigilance-inspections/ 2018-05-03T21:40:23+00:00 https://biolegacyresearch.com/ctti-plans-recommendations-on-investigators-decentralized-trials-and-mobile-technologies/ 2018-05-03T21:42:54+00:00 https://biolegacyresearch.com/time-between-plant-inspections-and-classification-letters-continuing-to-shrink-says-fda-official/ 2018-05-04T21:25:46+00:00 https://biolegacyresearch.com/fda-official-says-inspection-agreements-with-eu-authorities-done-by-next-summer/ 2018-05-04T21:27:21+00:00 https://biolegacyresearch.com/ama-report-synthetic-opioids-are-now-the-leading-cause-of-overdose-deaths/ 2018-05-04T21:28:20+00:00 https://biolegacyresearch.com/opioid-drugmakers-distributors-sued-for-skyrocketing-insurance-costs/ 2018-05-04T21:29:21+00:00 https://biolegacyresearch.com/fda-pulls-plan-for-risk-based-biologics-inspections-after-negative-comments/ 2018-05-04T22:00:28+00:00 https://biolegacyresearch.com/drug-patent-cases-jumped-30-percent-in-2017/ 2018-05-07T21:54:00+00:00 https://biolegacyresearch.com/ema-issues-prime-report-analyzing-its-first-two-years/ 2018-05-07T21:55:39+00:00 https://biolegacyresearch.com/icer-slams-cost-effectiveness-of-three-vertex-cystic-fibrosis-drugs/ 2018-05-07T21:56:34+00:00 https://biolegacyresearch.com/dea-bars-louisiana-wholesaler-from-distributing-opioids/ 2018-05-07T21:57:19+00:00 https://biolegacyresearch.com/drug-wholesalers-deny-contributing-to-opioid-epidemic-in-house-committee-hearing/ 2018-05-08T21:52:55+00:00 https://biolegacyresearch.com/fda-outlines-supply-chain-security-waiver-process/ 2018-05-08T21:53:46+00:00 https://biolegacyresearch.com/medicare-payment-structures-contributing-to-higher-drug-prices-says-verma/ 2018-05-08T21:54:41+00:00 https://biolegacyresearch.com/florida-drugmaker-draws-fda-warning-for-repackaging-distribution/ 2018-05-08T21:56:15+00:00 https://biolegacyresearch.com/novartis-paid-shell-company-run-by-trump-lawyer/ 2018-05-09T22:34:53+00:00 https://biolegacyresearch.com/omb-releases-spring-unified-regulatory-agenda/ 2018-05-09T22:35:58+00:00 https://biolegacyresearch.com/fda-advises-on-clinical-trials-for-uncomplicated-uti-treatments/ 2018-05-09T22:36:51+00:00 https://biolegacyresearch.com/house-democrats-urge-trump-to-address-medicare-price-negotiation-patent-abuse-in-drug-pricing-plan/ 2018-05-09T22:38:06+00:00 https://biolegacyresearch.com/tga-overhauls-advisory-committee-confidentiality-conflicts-of-interest-guidance/ 2018-05-09T22:39:13+00:00 https://biolegacyresearch.com/fda-clarifies-the-term-outsourcing-facility-and-requirements-for-503a-compounders/ 2018-05-10T21:46:05+00:00 https://biolegacyresearch.com/expert-committee-finds-akceas-nda-for-rare-genetic-disease-is-safe-and-effective/ 2018-05-10T21:46:57+00:00 https://biolegacyresearch.com/tufts-report-orphan-drugs-take-an-average-of-15-years-to-launch/ 2018-05-10T21:47:44+00:00 https://biolegacyresearch.com/mccaskill-fentanyl-seized-at-ports-of-entry-doubled-last-year/ 2018-05-10T21:48:44+00:00 https://biolegacyresearch.com/trump-announces-next-moves-in-fight-to-lower-drug-prices/ 2018-05-11T22:23:56+00:00 https://biolegacyresearch.com/fda-issues-advice-to-sponsors-of-pediatric-hiv-drugs/ 2018-05-11T22:24:43+00:00 https://biolegacyresearch.com/tennessee-joins-arizona-in-legalizing-off-label-drug-promotion/ 2018-05-11T22:25:30+00:00 https://biolegacyresearch.com/doj-sues-two-companies-using-experimental-stem-cell-drugs/ 2018-05-11T22:26:16+00:00 https://biolegacyresearch.com/mhra-cites-data-management-and-integrity-issues-in-gcp-inspection-report/ 2018-05-11T22:27:09+00:00 https://biolegacyresearch.com/administration-may-target-medicare-part-b-and-d-plans-in-efforts-to-lower-drug-costs/ 2018-05-14T21:41:02+00:00 https://biolegacyresearch.com/fda-proposes-to-drop-second-appeals-for-medical-product-classifications/ 2018-05-14T21:41:54+00:00 https://biolegacyresearch.com/aids-nonprofit-loses-patent-appeal-against-gilead/ 2018-05-14T21:42:47+00:00 https://biolegacyresearch.com/wyden-turns-up-heat-on-novartis-in-cohen-controversy/ 2018-05-14T21:49:50+00:00 https://biolegacyresearch.com/continuous-manufacturing-bill-would-pair-universities-with-fda-industry/ 2018-05-15T16:29:08+00:00 https://biolegacyresearch.com/florida-drugmaker-draws-fda-warning-for-repackaging/ 2018-05-15T16:30:05+00:00 https://biolegacyresearch.com/fda-ad-enforcement-targets-risk-information-pre-approval-promotions/ 2018-05-15T16:33:05+00:00 https://biolegacyresearch.com/ema-issues-qa-on-exposure-limits-and-prevention-of-cross-contamination/ 2018-05-15T16:34:05+00:00 https://biolegacyresearch.com/syncardia-systems-nailed-for-mdr-deficiencies/ 2018-05-15T17:22:51+00:00 https://biolegacyresearch.com/imdrf-roundup-updates-from-russia-brazil-australia-and-asia/ 2018-05-15T17:23:45+00:00 https://biolegacyresearch.com/483-roundup-devicemakers-cited-for-complaints-quality/ 2018-05-15T17:24:48+00:00 https://biolegacyresearch.com/fda-accepts-iec-standards-for-ultrasonic-diathermy-devices/ 2018-05-15T17:25:49+00:00 https://biolegacyresearch.com/fda-releases-guidance-on-quality-considerations-for-inhalers/ 2018-05-15T17:27:20+00:00 https://biolegacyresearch.com/eu-uk-seek-agreement-on-notified-bodies/ 2018-05-15T17:28:16+00:00 https://biolegacyresearch.com/japan-raises-medical-device-registration-fees/ 2018-05-15T17:29:06+00:00 https://biolegacyresearch.com/fda-spells-out-policy-for-multiple-function-devices/ 2018-05-15T17:30:07+00:00 https://biolegacyresearch.com/new-zealand-proposes-fee-hikes-for-devices/ 2018-05-15T17:30:56+00:00 https://biolegacyresearch.com/tga-conducts-product-safety-review-of-ventilators/ 2018-05-15T17:31:55+00:00 https://biolegacyresearch.com/340b-program-lacks-price-transparency-federal-watchdogs-tell-help-committee/ 2018-05-15T21:48:41+00:00 https://biolegacyresearch.com/west-virginia-says-consumers-cant-sue-brand-name-drugmakers-for-harm-caused-by-generics/ 2018-05-15T21:49:32+00:00 https://biolegacyresearch.com/abbvie-backtracks-on-huge-price-hike-for-cancer-drug/ 2018-05-15T21:50:24+00:00 https://biolegacyresearch.com/fda-approves-new-drugs-faster-than-five-international-agencies/ 2018-05-15T22:00:50+00:00 https://biolegacyresearch.com/vermont-becomes-first-state-to-allow-wholesalers-to-import-canadian-drugs/ 2018-05-16T21:48:05+00:00 https://biolegacyresearch.com/gottlieb-calls-on-clinical-trial-operators-to-find-ways-to-enroll-more-women/ 2018-05-16T21:48:49+00:00 https://biolegacyresearch.com/cms-updates-online-drug-spending-dashboard-adds-year-over-year-price-changes/ 2018-05-16T21:50:06+00:00 https://biolegacyresearch.com/fda-flags-data-inaccuracy-quality-issues-at-iqvia/ 2018-05-16T21:50:56+00:00 https://biolegacyresearch.com/drugmakers-call-for-more-clinical-trial-flexibility-in-alzheimers-drug-guidance/ 2018-05-17T21:51:29+00:00 https://biolegacyresearch.com/fda-reference-drug-list-flags-companies-that-hinder-generics/ 2018-05-17T21:52:17+00:00 https://biolegacyresearch.com/house-ec-committee-advances-over-30-opioid-bills/ 2018-05-17T22:05:28+00:00 https://biolegacyresearch.com/final-guidance-on-irb-written-procedures-allows-flexibility/ 2018-05-17T22:07:20+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-clinical-trials-for-hypogonadism/ 2018-05-18T22:19:54+00:00 https://biolegacyresearch.com/fda-warns-of-lower-survival-rates-for-certain-patients-in-keytruda-tecentriq-monotherapy-trials/ 2018-05-18T22:20:43+00:00 https://biolegacyresearch.com/retailers-sue-allergan-for-keeping-generic-restasis-off-market/ 2018-05-18T22:21:30+00:00 https://biolegacyresearch.com/fda-issues-draft-guidance-for-antimicrobial-drugs-for-cytomegalovirus/ 2018-05-18T22:22:18+00:00 https://biolegacyresearch.com/reine-lifescience-cited-for-adulterated-apis/ 2018-05-18T22:23:05+00:00 https://biolegacyresearch.com/fda-inspection-agreements-with-eu-done-by-next-summer/ 2018-05-21T16:31:09+00:00 https://biolegacyresearch.com/ema-issues-qa-on-health-based-exposure-limits/ 2018-05-21T16:32:58+00:00 https://biolegacyresearch.com/fda-issues-streamlined-trial-guidance-for-hematologic-drugs/ 2018-05-21T16:36:16+00:00 https://biolegacyresearch.com/fda-pulls-plan-for-risk-based-biologics-inspections/ 2018-05-21T16:38:00+00:00 https://biolegacyresearch.com/novartis-and-par-pharmaceutical-taken-to-court-over-pay-for-delay/ 2018-05-21T20:56:00+00:00 https://biolegacyresearch.com/fda-releases-final-guidance-on-acne-drug-trials/ 2018-05-21T20:57:00+00:00 https://biolegacyresearch.com/fda-updates-2013-guidance-on-validation-of-bioanalytical-methods/ 2018-05-21T22:10:28+00:00 https://biolegacyresearch.com/citizen-petition-asks-fda-to-shoot-down-ferrings-nocturia-treatment/ 2018-05-21T22:15:43+00:00 https://biolegacyresearch.com/ei-cited-for-manufacturing-human-drugs-and-pesticides-with-the-same-equipment/ 2018-05-21T22:16:43+00:00 https://biolegacyresearch.com/fda-releases-guidance-on-trials-for-active-ingredients-for-use-in-otc-monographs/ 2018-05-22T21:23:58+00:00 https://biolegacyresearch.com/former-valeant-and-philidor-executives-convicted-in-kickback-scheme/ 2018-05-22T21:24:46+00:00 https://biolegacyresearch.com/fda-warns-three-kratom-distributors-over-unproven-opioid-treatment-claims/ 2018-05-22T21:25:34+00:00 https://biolegacyresearch.com/house-sends-senate-right-to-try-bill-to-presidents-desk/ 2018-05-22T22:06:52+00:00 https://biolegacyresearch.com/more-fda-guidances-on-gene-and-cell-therapies-in-the-pipeline-gottlieb-says/ 2018-05-22T22:07:37+00:00 https://biolegacyresearch.com/fda-eases-enforcement-on-some-otc-sunscreen-products/ 2018-05-22T22:15:05+00:00 https://biolegacyresearch.com/fda-advisory-committee-votes-against-recommending-opioid-spray-for-acute-pain/ 2018-05-23T22:11:34+00:00 https://biolegacyresearch.com/fda-to-pull-otc-oral-benzocaine-products-unless-they-drop-teething-from-labels/ 2018-05-23T22:12:25+00:00 https://biolegacyresearch.com/drugs-for-inhalation-anthrax-will-be-considered-under-animal-rule/ 2018-05-23T22:13:18+00:00 https://biolegacyresearch.com/seniors-paying-more-for-generics-through-medicare-part-d-study-finds/ 2018-05-23T22:14:13+00:00 https://biolegacyresearch.com/pfizer-agrees-to-pay-nearly-24-million-to-put-kickback-claims-to-rest/ 2018-05-24T21:39:17+00:00 https://biolegacyresearch.com/administration-urges-scotus-to-review-merck-case-over-failure-to-warn-claims/ 2018-05-24T21:40:24+00:00 https://biolegacyresearch.com/u-s-cancer-drug-spending-nearly-doubled-from-2017-iqvia/ 2018-05-24T21:41:13+00:00 https://biolegacyresearch.com/ftc-loses-challenge-to-impax-endo-opioid-agreement/ 2018-05-28T20:32:00+00:00 https://biolegacyresearch.com/nonprofit-drugmakers-could-prompt-competitive-generic-pricing/ 2018-05-28T20:33:00+00:00 https://biolegacyresearch.com/cerno-pharmaceuticals-hit-with-warning-letter-over-adulterated-products/ 2018-05-28T20:34:00+00:00 https://biolegacyresearch.com/china-to-crack-down-on-drug-companies/ 2018-05-28T20:43:00+00:00 https://biolegacyresearch.com/eu-commission-proposal-would-boost-manufacture-of-generic-drugs-and-biologics-exclusively-for-export/ 2018-05-29T21:57:06+00:00 https://biolegacyresearch.com/gastro-intestinal-tears-meet-exclusion-criteria-for-clinical-trials-fda-says/ 2018-05-29T21:57:54+00:00 https://biolegacyresearch.com/state-ags-call-on-congress-to-increase-penalties-for-irresponsible-opioid-manufacturers/ 2018-05-29T21:58:45+00:00 https://biolegacyresearch.com/va-anti-opioid-efforts-lacking-gao-finds/ 2018-05-29T21:59:31+00:00 https://biolegacyresearch.com/chinese-firm-warned-for-data-integrity-record-maintenance-issues/ 2018-05-29T22:00:00+00:00 https://biolegacyresearch.com/trump-signs-right-to-try-into-law-hints-at-massive-drops-in-drug-prices/ 2018-05-30T21:49:41+00:00 https://biolegacyresearch.com/supreme-court-wont-hear-dismissed-bristol-myers-squibb-otsuka-whistleblower-case/ 2018-05-30T21:50:58+00:00 https://biolegacyresearch.com/fda-advises-on-how-to-consider-blood-pressure-effects-in-drug-development/ 2018-05-30T21:56:51+00:00 https://biolegacyresearch.com/fda-issues-draft-ich-guidance-on-pharmaceutical-product-lifecycle-management/ 2018-05-30T22:06:45+00:00 https://biolegacyresearch.com/gottlieb-announces-policies-to-address-rems-exploitation-by-brand-drugmakers/ 2018-05-31T21:51:11+00:00 https://biolegacyresearch.com/former-insys-sales-rep-pleads-guilty-to-paying-kickbacks-to-doctors/ 2018-05-31T21:52:02+00:00 https://biolegacyresearch.com/gottlieb-calls-for-expansion-of-fda-authorities-to-fight-iv-drug-shortages/ 2018-05-31T21:52:50+00:00 https://biolegacyresearch.com/fda-weighs-opening-up-adult-cancer-trials-to-adolescents/ 2018-06-01T21:40:21+00:00 https://biolegacyresearch.com/chmp-recommends-nine-medicines-for-approval-including-two-orphan-drugs/ 2018-06-01T21:41:15+00:00 https://biolegacyresearch.com/fda-issues-revised-guidance-on-developing-drugs-for-complicated-utis/ 2018-06-01T21:42:00+00:00 https://biolegacyresearch.com/australian-manufacturer-nailed-for-process-validation-and-testing-shortcomings/ 2018-06-01T21:48:37+00:00 https://biolegacyresearch.com/proactive-pharmacovigilance-essential-to-combating-opioid-epidemic-fda-says/ 2018-06-01T21:56:17+00:00 https://biolegacyresearch.com/mhra-cites-data-management-integrity-issues-in-gcp-inspections/ 2018-06-04T21:32:14+00:00 https://biolegacyresearch.com/cerno-pharma-hit-with-warning-letter-over-adulterated-products/ 2018-06-04T21:33:32+00:00 https://biolegacyresearch.com/fda-calls-out-manufacturer-for-maintenance-quality-control/ 2018-06-04T21:36:20+00:00 https://biolegacyresearch.com/scotus-urged-to-review-merck-case-over-failure-to-warn-claims/ 2018-06-04T21:37:09+00:00 https://biolegacyresearch.com/noven-pharmaceuticals-cited-for-quality-deficiencies/ 2018-06-04T21:37:52+00:00 https://biolegacyresearch.com/fda-cites-new-zealand-firm-for-multiple-violations/ 2018-06-04T21:38:39+00:00 https://biolegacyresearch.com/fda-unveils-plan-to-reorganize-cders-drug-reviews/ 2018-06-04T22:14:00+00:00 https://biolegacyresearch.com/gottlieb-touts-fda-plans-for-up-front-review-of-oncology-trial-data/ 2018-06-04T22:15:21+00:00 https://biolegacyresearch.com/fda-offers-recommendations-to-biosimilar-sponsors-on-agency-meetings/ 2018-06-04T22:16:32+00:00 https://biolegacyresearch.com/right-to-try-sponsor-tells-gottlieb-law-intends-to-reduce-fda-authority/ 2018-06-04T22:17:17+00:00 https://biolegacyresearch.com/otc-gel-manufacturer-cited-for-ingredient-testing-process-validation-failures/ 2018-06-05T21:44:42+00:00 https://biolegacyresearch.com/fda-hits-nine-online-operators-for-selling-unapproved-opioids/ 2018-06-05T21:46:00+00:00 https://biolegacyresearch.com/doctor-pleads-guilty-to-accepting-bribes-through-insys-fraudulent-speakers-bureau/ 2018-06-05T21:48:17+00:00 https://biolegacyresearch.com/hhs-kicks-340b-drug-price-ceiling-and-penalties-further-down-the-road/ 2018-06-05T21:50:00+00:00 https://biolegacyresearch.com/fda-attributes-savings-of-11-8-billion-in-drug-costs-to-generics/ 2018-06-05T22:00:00+00:00 https://biolegacyresearch.com/fda-offers-pdufa-waivers-for-antiretroviral-hiv-drugs/ 2018-06-06T21:42:21+00:00 https://biolegacyresearch.com/as-generic-drug-competition-increases-so-do-product-recalls-study-finds/ 2018-06-06T21:43:38+00:00 https://biolegacyresearch.com/fda-warns-korean-firm-for-inadequate-quality-controls-testing/ 2018-06-06T21:44:29+00:00 https://biolegacyresearch.com/fda-calls-out-pennsylvania-manufacturer-for-equipment-maintenance/ 2018-06-06T21:45:23+00:00 https://biolegacyresearch.com/fda-moves-to-improve-device-safety-through-competition-around-safer-design/ 2018-06-07T17:37:09+00:00 https://biolegacyresearch.com/fda-rejects-new-device-regulation-for-third-party-servicers/ 2018-06-07T17:38:37+00:00 https://biolegacyresearch.com/canada-makes-additional-adjustments-to-mdsap-program/ 2018-06-07T17:39:29+00:00 https://biolegacyresearch.com/no-regulatory-changes-for-australias-personalized-and-3d-printed-devices/ 2018-06-07T17:40:26+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-six-firms-over-design-controls-data-integrity/ 2018-06-07T17:41:24+00:00 https://biolegacyresearch.com/india-releases-guidance-on-essential-safety-and-performance-principles/ 2018-06-07T17:44:13+00:00 https://biolegacyresearch.com/fda-seeks-comment-on-medical-device-software/ 2018-06-07T17:44:58+00:00 https://biolegacyresearch.com/kroger-walgreens-sue-jj-for-suppressing-remicade-biosimilars/ 2018-06-07T22:00:23+00:00 https://biolegacyresearch.com/doj-issues-new-indictments-in-opioid-prescription-scheme/ 2018-06-07T22:01:06+00:00 https://biolegacyresearch.com/australian-api-manufacturer-draws-fda-warning-over-quality-investigations/ 2018-06-07T22:01:49+00:00 https://biolegacyresearch.com/ftc-says-hatch-waxman-patent-infringement-suits-are-not-antitrust-proof/ 2018-06-08T21:18:03+00:00 https://biolegacyresearch.com/stakeholders-urge-tweaks-in-draft-guidance-on-pregnant-trial-subjects/ 2018-06-08T21:19:00+00:00 https://biolegacyresearch.com/semiannual-agenda-flags-upcoming-fda-regulatory-actions/ 2018-06-08T21:41:48+00:00 https://biolegacyresearch.com/lawmakers-to-consider-drug-pricing-opioid-bills-this-week/ 2018-06-11T22:02:01+00:00 https://biolegacyresearch.com/fda-generic-drug-approvals-inch-upwards/ 2018-06-11T22:02:47+00:00